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A B S T R A C T
One of the main reasons for the difficulty of providing a treatment of a huge number
of disorders and diseases, especially for a complex organ as the brain, is the lack
of deeper insight on how it actually works. And even after centuries of research,
at present there are no efficient tools at hand to create this deeper insight yet. Re-
cently, an increasing attention is focused on an emerging interdisciplinary field called
organic bioelectronics, aimed at engineering, fabrication and characterization of im-
proved biocompatible, conformable and low cost processing devices that enable stim-
ulation and recording of neural cells in vitro and in vivo, providing an unprecedented
insight into the brain’s physiology and pathophysiology. These new devices are hot
candidates in order to create efficient tools for research and diagnosis and to establish
a working ’machine-to-brain’ communication.
Still there is a lot of room for improvement in the used materials, for example in the
biocompatibility. To this aim, a novel quaterthiophene (T4) semiconductor, covalently
modified with lysine- ends (T4Lys), was fabricated and characterized, rendering addi-
tional surface coating unnecessary. The material was then tested as interface for DRG
primary neurons. By whole-cell patch-clamp, it was examined if the biofunctionality
of neurons cultured on T4Lys was preserved and if T4Lys as an organic interface
enabled functional differentiation of DRG primary neurons.
Not only neurons but also astrocytes, their ion channels and calcium signalling
play a crucial role in the physiology and pathophysiology of the central nervous
system. In this context novel tools are needed to also monitor and/or modulate the
astrocytic biochemical and bioelectrical activity. To this end, an organic field effect
transistor device (O-CST), previously reported to enable real-time recording and ma-
nipulation of communication signals of primary neurons, was interfaced with pri-
mary astroglial cells. In this context the biocompatibility of the organic material P13
and its preservation of the astrocytic electrophysiological properties in vitro was in-
vestigated, and the impact of a P13-based organic field effect transistor on the astro-
cytic ionic conductance studied. The evoked astrocytic response to device stimulation
was bio-physically and pharmacologically characterized and the necessity of device
integrity investigated.
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1
M O T I VAT I O N
1.1 motivation
The human brain is probably the most complex of organs and understanding how
it works is one of the greatest challenges science and engineering are facing. But
the brain was not always held in high regard: perhaps the most stunning and best
known feature of the ancient Egyptian mummification is the neglect of the brain.
When creating a mummy, the brain was often removed transnasally and thrown away,
while the other internal organs were carefully preserved [1]. The Greek philosopher
Aristotle attributed the location of intelligence and thought to the heart, while the
brain would serve as a cooling agent for body heat. The birth of neuroscience might
have begun in the 4th century BC with a contemporary of Aristotle: Hippocrates, one
of the most influential medical doctors of all times. Hippocrates identified the brain
as the seat of thought, perception, consciousness and the center of intelligence and
emotion [2, 3]. It was an historic step, but a deeper insight and a first understanding
of the brain’s anatomy and function took a long time to follow. Instead, neuroscience
was more than once on the wrong track, among which Galen’s fluid filled ventricle
theories of the brain dominated until well into the 17th century [4].
Centuries later, mankind has made important progress in the understanding of
biological systems, body functions and the generation of diseases. Still a complete
understanding of the function of the brain, the constant interaction of 50-100 billion
neurons or their tasks, the involvement of astrocytes in memory and signalling re-
mains and the pathophysiology of a huge number of disorders and diseases remain
to be explored [5].
The WHO World Health report of 2001 states that one in four people worldwide
will be affected by mental or neurological disorders at some point in their lives [6].
For 2015, the Alzheimer’s association expected an estimated number of 5.3 million
Americans to have Alzheimer’s disease [7]. The WHO report Neurological disorders:
public health challenges of 2006 lists the prevalence of neurological disorders by cause
(including epilepsy, dementia, Parkinson’s disease, multiple sclerosis, migraine and
others) predicting for 2015 worldwide 148 out of 1000 people affected by any of these
disorders. A figure that has to be seen in the context of more than 7 billion people
currently living on the planet - and this number is increasing [8].
Even though great efforts have been taken and scientific progress has been made,
for many of these brain-based pathologies, neither a cure nor an effective treatment
or prevention has been found to date. One of the main reasons for the difficulty of
providing a treatment, especially for a complex organ as the brain, is the lack of
deeper insight on how it actually works. On the other hand at present, research and
medicine have no efficient tools at hand to create this deeper insight yet [5].
Constructing these efficient tools to develop a working ’machine-to-brain’ commu-
nication is the challenge of translating the "electron" world of electronic devices into
the biological "ionic" world [9].
3
4 motivation
Recently, an increasing attention is focused on an emerging interdisciplinary field
called organic bioelectronics, aimed at engineering, fabrication and characterization
of improved biocompatible, conformable and low cost processing devices that enable
the stimulation and recording of neural cells in vitro and in vivo, seeking to enable
an unprecedented insight into the brain’s physiology and pathophysiology and to
become a stepping stone in bridging the brain to the world.
1.2 thesis outline
To date, all currently available bio-electronic approaches still require additional treat-
ment of the semiconductor surface to enable cell adhesion. Based on data provided
on inorganic neuro-electronic interfaces, it is plausible to suppose that this additional
surface coating might cause a decrease of the recording sensibility of organic inter-
faces, by increasing the cleft distance between electrodes and cells [10, 11, 12]. To this
aim, a novel quaterthiophene (T4) semiconductor covalently modified with lysine-
ends (T4Lys) was fabricated and characterized, rendering additional surface coating
unnecessary. The material was then tested as interface for DRG primary neurons. By
whole-cell patch-clamp, I tested if
• the biofunctionality of neurons cultured on T4Lys was preserved
• and if T4Lys as an organic interface enabled functional differentiation of DRG
primary neurons
as described in Chapter 4.
Not only neurons but also astrocytes, their ion channels and calcium signalling,
play a crucial role in the physiology and pathophysiology of the central nervous sys-
tem. Taking this importance of astrocytes in the brain and their involvement in a
broad range of diseases and disorders into account, novel tools to monitor and mod-
ulate also astrocytic biochemical and bioelectrical activity in vitro and in vivo is a de-
mand not met by the currently available technology. The group of Dr. Valentina Benfe-
nati at the CNR in Bologna previously reported on transparent Organic Cell Stimulat-
ing and Sensing Transistors (O-CSTs) capable of providing bidirectional stimulation
and recording of primary DRG neurons. These organic devices were fabricated with a
bottom-gate top-contact transistor architecture and N, N’-ditridecylperylene-3,4,9,10-
tetracarboxylic diimide (P13) as semiconducting and capping layer [13, 14]. However
the possibility to use the introduced O-CST device to monitor and manipulate also
astroglial ion channel conductance and calcium signaling remained to be elucidated.
To this end, I
• investigated the biocompatibility of P13 and its preservation of the astrocytic
electrophysiological properties in vitro,
• studied the impact of a P13-based organic field effect transistor on the astrocytic
ionic conductance,
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• bio-physically and pharmacologically characterized the evoked astrocytic re-
sponse to device stimulation,
• investigated the necessity of device integrity for the obtained astrocytic re-
sponse,
• studied the astrocytic calcium response to device operation
as described in Chapter 5.
All activities were developed thanks to the collaboration with a broad team of
researchers of institutes CNR-ISMN and CNR-ISOF in Bologna, E.T.C srl as well as
the institute of physiology within the department of pharmacy and biotechnology
(FaBiT) of the University of Bologna.
1.3 the olimpia project
The research for this thesis was funded by the olimpia project under EU-FP7-2012-
PEOPLE-ITN Marie Curie Actions Grant Agreement 316832. olimpia was a training
network initiative built on research and development of innovative organic optoelec-
tronic devices, interfaced and integrated with living systems. The living systems of
choice were neural cells (astrocytes and neurons) to be interfaced and integrated in
vitro and in vivo with different organic electronic and optoelectronic devices. The
olimpia research was aimed to provide radically new understanding of neural cell-
cell communication processes and to have an impact on a wide variety of fields,
from biomedical research to neuro-regenerative medicine. The olimpia consortium
was both: interdisciplinary and intersectorial. The consortium combined 9 partners
belonging to 6 European countries from academia, public research centers and indus-
trial laboratories.
The specific scientific and technical objectives of olimpia, to be achieved through
an intensive collaborative research program detailed in the next sections, were:
• To develop and fully characterize organic optoelectronic devices suitable for
operation in physiological aqueous environment.
• To investigate thin film structures and organic optoelectronic devices that pre-
serve glial cells and neuron bioelectrical functionality in vitro and/or in vivo.
• To fabricate organic optoelectronic devices integrated with neural cells capable
of providing stimulation and transduction of neural cells bioelectrical activity
in vitro and/or in vivo.
• To explore the potential application of organic devices as diagnostic tool for
epilepsy and neuro-regenerative medicine.
olimpia activities were aimed at getting a fundamental understanding of the mu-
tual interaction between organic optoelectronic materials and devices and neurobiol-
ogy. The research approach conceives the living systems of neural cells as integrated
and interactive components of the device [15].

2
B I O E L E C T R O N I C I N T E R FA C E S
2.1 the ionic basis of membrane potentials
In 1952, Hodgkin and Huxley recorded sodium currents (INa) for the first time, using
their voltage-clamp technique on the squid giant axon. They inserted electrodes into
these giant neurons and measured so the membrane potential in rest and during
excitation. They developed a mathematical model (see figure 1) of the ion flux of
K+ and Na+ through the axon membrane, based on their finding that the membrane
potential and the ionic currents were correlated. In their model, the different elements
of the cell membrane were regarded as electrical elements. The lipid bilayer of the
membrane was thought as a capacitor, voltage-gated K+ and Na+ channels were
represented as non-linear electrical conductances, leak channels as linear ones [16].
Figure 1: Scheme of the equivalent circuit of the Hodgkin-Huxley model for the membrane of
a giant squid axon, representing the biophysical characteristic of cell membranes. The lipid
bilayer is represented as a capacitance (Cm) in this model. Voltage-gated ion channels are
represented as nonlinear (GK, GNa), leak ion channels as linear (GL) conductances, respec-
tively. The electrochemical gradients driving the flow of ions are represented as batteries (E).
(Modified from [16])
At that time, the detection of the actual charge movement was technically impos-
sible, still Hodgkin and Huxley deducted that there must be an ion flux across the
membrane for each movable membrane charge. They proposed that this transmem-
brane flux was happening at "active patches" in the membrane. These "active patches"
were later found to be voltage-gated K+ and Na+ channels. Based on this work,
Hodgkin and Keynes found that these currents could be best explained if ions were
passing through narrow pores, which they named channels [17]. Finally with the in-
vention of the patch-clamp technique by Neher and Sakmann in 1976, it was possible
to measure also currents through single ion channels [18].
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In nerve cells, muscle fibers and cardiomyocytes, electrical signals are generated by
changing the permeability of the cell membrane to ions. Changes in the membrane
permeability, which means changing the open/close state of the membrane ion chan-
nels, allows ions to move across the membrane, following their electrochemical gradi-
ent. At rest, a cell has a steady electrical potential across the plasma membrane with
the intracellular space being more negative with respect to the extracellular space.
Figure 2: Ion distributions in a model cell of the giant squid axon. The cell membrane is here
permeable to K+, Na+ and Cl−, but impermeable to organic anions (A−) within the cell.
With the given ion concentrations (in mM), and a relative cell permeability for K+, Na+ and
Cl− of 1.00 : 0.04 : 0.45 the membrane potential calculated with equation 1 is around -60
mV at 20◦C. The blue arrows indicate the ion flux direction according to the concentration
gradient, the red arrows along the electrical gradient. In a cell in the resting state, these two
forces are in equilibrium and the net flux is zero. (Modified from [19])
In figure 2, a model cell for the giant squid axon is shown, with given ion concen-
trations for K+, Na+ and Cl−. Following the concentration gradient (blue arrows),
potassium diffuses out of the cell, while sodium and chloride diffuse in. The mem-
brane potential can be exactly in balance so there is no net flux across the membrane
- this membrane potential is composed of the equilibrium potentials of the present
ions. In order to maintain the concentration gradients between the intra- and extra-
cellular space, the Na/K ATPase transports K+ and Na+ ions actively under the use
of ATP against their concentration gradients [19].
Vmem =
RT
F
log
ρK [K]o + ρNa [Na]o + ρCl [Cl]i
ρK [K]i + ρNa [Na]i + ρCl [Cl]o
(1)
The Nernst equation can be used to calculate the equilibrium potential of each
ion and of the whole cell, once the ion concentration gradients across various mem-
branes are known. A modification of it, the so called Goldman-Hodgkin-Katz equa-
tion (equation 1, derives the membrane potential (Vmem) instead of equilibrium po-
tentials and conductances from ion concentrations inside [A]i and outside [A]o the
cell together with the membrane permeability (ρ) for each ion. R is the universal gas
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constant, T the temperature and F the Faraday constant. Increasing the concentration
of one ion or its permeability leads in turn to a change of the membrane potential
[20, 21].
2.2 electrophysiological signals of neural cells
2.2.1 Ion Channels and action potentials in neuronal cells
Neurons and other excitable cells communicate by sequences of fixed-size electrical
impulses that are called action potentials. An action potential is a short-lasting (about
5 ms) localized change in the electrical potential of the cell membrane. The membrane
potential of an excitable cell thereby rapidly rises and falls, following a consistent
trajectory. A schematic representation is shown in figure 3 with a brief description
of an action potential’s different phases and the involved ion channels. In neuronal
cells, action potentials are transmitting the excitement along the axon for cell-to-cell
communication. Over a certain threshold, an action potential is unstoppable released
following the "all or none"-law [22, 23].
Figure 3: Schematic representation of an action potential (red line). (1) Membrane potential
in the resting state, (2) voltage threshold leading to firing of an action potential due to the
opening of voltage-gated Na+ channels (blue background) and influx of Na+-ions, (3) depo-
larization phase, the cell membrane depolarizes further by opening of more Na+-channels
(purple background). In the repolarization phase (4), voltage-gated K+-channels are open-
ing (yellow background), permitting a K+-efflux, while the voltage-gated Na+-channels are
closed. The strong efflux of K+-ions is leading to an undershoot or hyperpolarization (5) of
the membrane potential, preventing the cell from firing again. The closing of the voltage-
gated K+-channels and voltage-gated Na+-channels returning to the resting state allows the
membrane to restore the resting potential (1), which is maintained by the K+-Na+-pump
until further firing of the cell. Modified from [24, 25].
The ability of neurons to conduct, transmit, and receive information in form of
electric signals results from the opening and closing of specific ion channels. One of
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the key players in excitable cells in general are voltage-gated sodium channels (NaV).
NaV are deactivated at negative potentials around the resting membrane potential of
about -70 mV [16, 23].
Membrane depolarization leads to a fast influx of sodium ions which causes a
reversion of the plasma membrane polarity. This depolarization in turn rapidly in-
activates NaV within a few milliseconds. As the Na+-channels close, sodium ions
can no longer enter the neuron, and they are actively transported out of the plasma
membrane. K+-channels are then activated and the K+-outward current is returning
the electrochemical gradient to the resting state. In order to prevent an action po-
tential from traveling back, the membrane potential undergoes a transient negative
shift, called hyper-polarization or refractory period. It occurs due to the combination
of closed sodium and open potassium channels, when the re-polarization is head-
ing towards the equilibrium potential of potassium ions (-75 mV) [26, 27, 28]. The
closing of the voltage-gated K+-channels and voltage-gated Na+-channels returning
to the resting state allows the membrane to restore the resting potential, which is
maintained by the K+-Na+-ATPase until further firing of the cell.
2.2.2 Ion channels and Calcium signalling in astrogial cells
After their discovery, astroglial cells were long regarded as merely supportive glue
within the central nervous system (CNS) [29]. This then common opinion slowly
changed with the finding of a large number of G-protein coupled receptors (GPCRs)
among other receptors for neurotransmitters in astrocytes [30, 31]. Rather strikingly,
the existence of most of the ion channels (and several receptors) that were discov-
ered in neurons, could step by step also be confirmed in astrocytes. The following
paragraph introduces briefly the most important types of ion channels in glial cells:
The first biophysical studies on astrocytes, more than 50 years ago, demonstrated
that glial cells show a hyperpolarized resting potential (-70 to -90 mV) relative to neu-
rons and a large K+-permeability [32, 33]. The resulting finding of K+-channels was
therefor rather unsurprising, also because the resting membrane potential, predicted
by the Nernst equation, was implicating their presence [34]. The resting membrane
potential in astrocytes is primarily established by inward rectifying K+ (Kir) channels
that are open close to the resting potential and closed at more depolarized potentials.
These channels are mainly responsible for the whole-cell current profile of astrocytes,
displaying larger currents negative of the resting potential and smaller ones at poten-
tials that are more positive. Kir channels have been found to have their conductance
blocked by Cs+ and Ba2+ [35, 36]. The inwardly rectifying K+- channel Kir 4.1 is
expressed exclusively in glial cells of the CNS. Other types of K+-channels that were
found to be expressed in astrocytes are outwardly or delayed rectifying K+ channels
(Kd), transient "A"-type channels (Ka) and Ca2+-activated K+-channels (KaCa).
The first demonstration of voltage-activated Na+-channels with the patch-clamp
technique was on cultured rat cerebral astrocytes [37]. In comparison to neurons,
Na+ expression densities are about three-fold smaller in almost all types of glial cells
[38, 39]. As astrocytes do not generate action potentials, it was suggested in studies
on TTX-sensitive Na+-channels that they create a "return" pathway for the K+-Na+-
ATPase, possibly modulating the K+-reuptake from the extracellular space [34].
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All cells express transporters and ion channels to move Cl-, bicarbonate and other
anions across the cell membrane, with Cl- being the primary negative charge carrier.
Also glial cells are no exception to this; still their anion channels are probably their
least well studied channels, even though they have been demonstrated in cultured as-
trocytes. Most is hereby known of volume regulated anion channels (VRACs). These
channels have been discussed as release routes for transmitters such as ATP [40, 41].
After the discovery of this broad variety of ion channels expressed in astrocytes,
they were regarded as electrically non-excitable cells, carrying out various impor-
tant duties in the CNS with their primary responsibility on creating and controlling
the optimal homeostatic environment for neuronal function. Astrocytes maintain the
physiological levels of ions and transmitters in the brain, as well as the pH. [42, 43].
One part of the astrocytic regulation of neurotransmitter levels is the excitatory amino
acid glutamate. The astrocytic clearing activity prevents the brain from a toxic accu-
mulation of glutamate. And also the re-uptake and recycling of glutamate to glu-
tamine in astrocytes plays an important role in the normal glutamate supply for the
inhibitory and excitatory synapses. Neurons use the "recycled" glutamine provided
by astrocytes to again transform it into active glutamate for synaptic transmission
[44, 45].
Another major astrocytic duty is the maintenance of the brain’s water homeostasis.
In particular the astrocytic endfeet express the bidirectional water channel aquaporin-
4 (AQP4) that together with K+-channels enables astrocytes to play a pivotal role in
the brain’s water homeostasis and spatial buffering of extracellular potassium [46, 47].
These astrocytic terminal processes enwrap the brain capillaries, enabling the control
of the cerebral blood flux, regulating vasodilation and vasoconstriction, and induce
endothelial cells during development to form tight junctions which create the basis of
the blood-brain barrier [48, 49, 50]. As astrocytes are in the favorable position to be in
contact with the cerebral blood vessels as well as with neuronal axons and synapses,
it is currently discussed that they also play a role in the brain metabolism. In the brain,
glycogen is found predominantly in astrocytes and by them broken down to lactate
during hypoglycemia and transferred to adjacent neurons. Also during periods of
intense neuronal activity, it is astrocytic glycogen that ensures the energy supply and
the preservation of neuronal function [51, 52].
Last but not least in this non-exhaustive description of glial duties in the CNS,
the astrocytic response to diverse forms of brain injury must be mentioned. Under
normal circumstances, the brain is very well protected from the entry of immune
cells, plasma proteins and other harming molecules on the basis of polarity and size
by the blood-brain barrier. In case of an acute trauma, stroke or other CNS disorders,
it is astrocytes that detect and integrate the signals of damage and inflammation and
regulate the neuroinflammatory response. Astrocytes respond to brain injury with
changes in their gene expression and morphology and by proliferation they form a
physical barrier to seal off the injury site, prevent entry of harming molecules and
keep the inflammation local. This process is referred to as reactive (astro-)gliosis
[53, 54, 55, 56].
But still, for not being able to fire action potentials, astrocytes where thought to be
unable to actively participate in brain information processing [31].
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calcium signalling as a form of cellular excitability. In the early
1990s, the view on astrocytes was challenged again with the discovery that local ap-
plication of glutamate can trigger cytosolic Ca2+-elevations in astrocytes that can
propagate as Ca2+-waves to neighboring cells [57]. Astrocytes were then found to
react to a variety of external stimuli, such as electrical activity of neurons, neurotrans-
mitters, changes in the osmolarity balance or even mechanical stress with intracellular
calcium ([Ca2+]i) elevations [58].
The origin of the Ca2+ for these Ca2+-elevations can be either Ca2+ entering
from the extracellular space or Ca2+ depleted from the intracellular stores [59]. A
schematic to summarize the various ways of Ca2+ entry is shown in figure 4. Ex-
periments on astroglial cells have shown that physiological stimulation triggers the
production of inositol 1,4,5-triphosphate (IP3) via the phospholipase C pathway. Ac-
tivated by the G-protein coupled metabotropic glutamate (mGLUr) and purinergic
(P2Y) receptors, PIP2 is broken down into Diacylglycerol (DAG) and IP3. IP3 can
either bind on IP3R2 receptors on the endoplasmic reticulum to release calcium or
propagate through gap junctions to neighboring cells to induce Ca2+-elevations [60].
On the other hand, a rise in [Ca2+]i can be produced by an influx of extracellular
Ca2+ entering the cell through different ionotropic receptors such as the glutamate
receptor (iGLUR) or the purinergic receptor P2X7 [61]. Hemichannels, constituted
of Connexin 43, are permeable to small physiological molecules like Glutamate and
ATP and may also be involved in astrocytic calcium signalling [62]. Moreover, extra-
cellular Ca2+ can enter astrocytes through voltage gated calcium channels (VGCC)
or by activation of transient receptor potential channels (TRP), a wide family of chan-
nels from which several of them were shown to be expressed in astroglia. Among
those, for example some isoforms of TRPC channels were described to be stretch-
activated channels and linked to store-operated Ca2+-entry. They also mediate large
Na+ fluxes that are associated with the endoplasmatic reticulum Ca2+-release [63].
the trpv4 channel . A member of the vanilloid subfamily of TRP channels
(TRPV), namely TRPV4, was discovered to be highly abundant in astrocytic endfeet
and described as a non-selective cation channel with a high permeability for Ca2+
and a lower one for other monovalent cations [64]. TRPV4 channels were found to be
activated by a variety of stimuli, including osmotic changes in the cell environment,
mechanical stimulation, changes in temperature, chemicals like phorbol esters (such
as 4αPDD [65]) and changes in [Ca2+]i [66, 67, 68, 69]. TRPV4 mediated currents
were found to be blocked by the unspecific blockers Ruthenium Red, Gadolinium
chloride and the TRPV4 selective inhibitor RN-1734 [70, 71]. TRPV4 channels have
also been associated with regulatory volume decrease (RVD) thereby interacting as
an osmosensor with the water channel Aquaporin4 (AQP4). TRPV4 provides a Ca2+-
signal for the activation of potassium and anion channels that leads to an efflux of
these osmolytes followed by water [72, 73, 74].
the trpa1 channel . TRPA1 is the only member of the ankyrin subfamily of
TRP channels expressed in mammals. It is a cation channel like TRPV4, yet poorly
selective to Ca2+. Initially, TRPA1 was described as a mediator of noxious cold stim-
uli in sensory neurons, because this channel responds to cold. However, this view
is currently under debate, because more recent studies were not able to confirm
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Figure 4: Mechanisms of calcium increases in astrocytes (modified from Agulhon et al. [31])
this cold-sensitivity [75]. In astrocytes, TRPA1 channels were described as regulators
of astrocytic basal Ca2+-levels and a blockade was found to reduce long-term po-
tentiation in hippocampal neurons [76]. TRPA1 channels were reported to mediate
spatially confined and slow-decaying [Ca2+]i increases and can be blocked specifi-
cally by the TRPA1 antagonist HC-030031 [77, 78]. TRPA1 is embedded into the cell
lipid membrane and strongly interacting with it. Therefor an activation by mechanical
stimulation is discussed, but also reagents, such as trinitrophenol and lipopolysaccha-
rides that integrate into the membrane are able to indirectly activate TRPA1. TRPA1-
channels can also be activated by a rather broad variety of chemical stimuli, such
as extracts from mustard and pungent roots, cinnamon, onions and garlic. TRPA1
is also described to be activated by oxidative stress during inflammatory processes,
when 4-hydroxy-nonenal and acrolein accumulate during an inflammation [79].
2.2.3 Astrocytic dysfunction in neurodegeneration.
Given the fact, that Ca2+ acts as an ubiquitous messenger within cells and therefor
a tight control over [Ca2+]i is necessary, it is only plausible to assume that a deregu-
lation of Ca2+-homeostasis leads to cellular malfunction. So it is rather unsurprising
that aberrant Ca2+-signaling in astrocytes has been reported to play a role in wide
range of neuropathologies, including ischemia, different forms of dementia, but also
autism and migraine [80, 42, 81]. But not only aberrant Ca2+-signalling adds a major
contribution to brain diseases - any astrocytic malfunction can and often will assist
to the formation or onset of an illness. For example the dysfunction of a major astro-
cytic K+-channel, namely Kir4.1, has been described in the context of Huntington’s
disease, where a decrease in functional expression of this channel was attributed to
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increased extracellular K+, which in turn lead to striatal medium spiny neuron dys-
function. The increased firing of these neurons in vivo is a characteristic feature of
Huntington’s disease [82]. A loss of Kir4.1 was also described in Alzheimer’s disease
and amyotrophic lateral sclerosis [83]. This channel has, among other K+-channels,
also been described in epilepsy, where the occurrence of seizures could be attributed
to a disturbed clearance of extracellular K+ and those abrogated K+-buffering mech-
anisms were found to lead to a disturbed re-polarization of neurons [84, 45].
Astrocytes were also found to play a major role in brain edema. The water channel
AQP4 expressed (primarily) in their endfeet controls water fluxes into and out of
the brain parenchyma, but also contributes to cytotoxic edema following traumatic
brain injury. As the brain is encapsulated in the skull, it has only very limited space
for volume enlargement, which creates an elevated intracranial pressure that may
lead to neuronal death. An increase in AQP4 expression is observed in reactive astro-
cytes after a traumatic brain injury, enabling such an undue brain swelling. Moreover
AQP4 is also dispersed in the cytoplasm in reactive astrocytes. On the other hand,
studies demonstrated that mice lacking AQP4 were protected from edema produced
by water intoxication, resulting from water uptake due to the traumatic disruption
of the blood-brain barrier. In addition to cerebral edema, accumulating evidence sug-
gests that AQP4 participates in the onset and progression of Alzheimer’s disease,
Parkinson’s disease and depression [85, 86, 47, 87]. Moreover, an extreme decrease in
the abundance of AQP4 channels in the membranes of hippocampal astrocytes was
found in patients with epilepsy [88].
In schizophrenia, post-mortem brains did not show degeneration of neurons but
abnormalities in the morphology of astrocytes, together with anomalistic expression
of several astrocyte-related genes. Also hypofunction of NMDA receptors as well as
aberrant astrocytic glutamate homeostasis have been discussed in order to find expla-
nations for the neurobiology of schizophrenia [89]. As evidence accumulated that in
the case of schizophrenia glial cells (instead of neurons) play the leading role and find-
ings of increased microglial densities supporting the hyothesis that proinflammatory
cytokines might be relevant in the development of psychosis, also the investigated
therapies focus now on astrocytes as potential targets for novel therapeutic agents
[90]. Seeing astrocytes as one of the key-players in brain pathophysiology, it has to
be underlined that it is high time for this expansion of focus.
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2.3 current technologies for electrophysiological recording
2.3.1 The Patch-Clamp technique
The physiology of ion channels has always been a main topic of interest in neuro-
science research. The patch-clamp technique is currently the gold standard for real-
time investigation of ion channel conductance, because it allows the investigation of
a small set of ion channels down to single-channel recording. The technique can be
applied on single cells in culture as well as on freshly prepared slices of tissue, on
cell bodies or on their processes [91]. A scheme representing the equivalent electrical
circuit is shown in figure 5. To isolate a membrane patch electrically, a thin glass
pipette with a blunt tip is sealed onto the membrane, then mild suction is applied to
establish a high-resistance seal in the gigaohm range (cell-attached configuration, see
6). Thereby all ions passing through this membrane patch flow into the pipette and
can be recorded by a chlorinated silver electrode connected to an electronic amplifier.
A grounded bath electrode is used to set the zero level. For many patch-clamp ap-
plication, the whole-cell configuration is the method of choice. By a pulse of suction or
voltage, the membrane is ruptured, creating a direct access to the cell interior. In the
the voltage-clamp configuration, the voltage of the whole cell to be set and controlled,
allowing the current response of the cell to be studied. In the the current-clamp config-
uration, a defined current is injected into the cell, while the cellular voltage response
is monitored [92, 93, 94].
Figure 5: Electrical circuit of a patch-clamp setup. Modified from [95].
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Figure 6: Schematic representation of a cell-attached patch-clamp configuration, where cur-
rents through few ion channels of the captured membrane patch can be measured. Rupturing
the membrane in this configuration allows to measure currents over the membrane of the en-
tire cell (whole-cell configuration). Modified from [95].
With its unbeaten signal resolution, complex biophysical properties of different
ion channels can be studied in depth. Nevertheless the major disadvantage of this
technique is its limitation to stimulation and recording of single cells, and therefore
neither suitable for high-throughput screening nor for studies on more elaborate
neuronal-astrocytic networks.
2.3.2 Multielectrode Array
The main methodology so far for extracellular recording, to provide real-time in-
sight into neuronal network activity and deciphering specific neural interactions and
circuits, is the use of substrate-integrated multielectrode arrays (MEAs, figure 7A).
These two-dimensional arrangements of multiple electrodes are platforms with elec-
trodes and interconnections based on metals and inorganic semi-conducting materi-
als. The high conductivity and high-definition processability with microfabrication
technologies, such as vacuum deposition, made these materials so far the materials
of choice [96]. Even though MEAs based on flexible substrates have already been
realized, most commercially available MEAs remain to be fabricated on glass sub-
strates, due to its transparency and robustness, but also in regard of cost-efficient
mass production [97].
The MEA system allows, unlike the patch-clamp technique, the recording with
multiple electrodes at a time (in figure 7B, four recording sites of the 64 are shown),
rather than recording from single cells. The researcher has also the choice to selec-
tively address different recording sites of one MEA, allowing to set up controls within
the same experiment [98]. Moreover, extracellular recording leaves the cell membrane
2.3 current technologies for electrophysiological recording 17
Figure 7: (A) Commercially available MEA used as a reference in our laboratory. (B) Light
microscope image of a cardiomyocyte culture (HL-1 cell line, 40x magnification) on the MEA
shown in (A). The recording sites are marked by the red arrows. (pictures taken by Saskia
Karges)
intact, for as a non-invasive technique, it does not require the breaching of the mem-
brane [99].
Apart from the advantages of the MEA, enabling simultaneous recording of extra-
cellular field potentials generated by action potentials, it still lacks the sensitivity to
record also the sub-threshold synaptic potentials and moreover it is not suitable for
the recording of electrically passive cells in the nervous system, such as astrocytes
[100]. Additionally, their greatest disadvantage comes with their rigidity and me-
chanical stiffness of the silicon based platforms, making them unsuitable for in vivo
studies or as implants [14, 96]. Rigid implants tend to damage the surrounding tissue
during insertion and impose chronic stress onto the sensitive biological environment
due to arising mechanical forces [96, 101]. Injuries in the CNS lead to complex cellular
interactions in order to repair the initial tissue damage by triggering a major glial re-
sponse referred to as reactive gliosis. But not only acute injuries are able to cause such
an immune reaction, also a lack of biocompatibility of the used material can. In both
cases, microphages nest in on the area followed by the recruitment of microglia of
the immune system which start to proliferate. Then astrocytes are activated to clear
the leftovers which is a fruitless effort in case of an artificial implant, for they are
normally built to be resistant to bio-degradation. The result is a "frustrated phagocy-
tosis" leading to a dense glial scar, encapsulating the implant to isolate it from the
surrounding delicate tissue within shortest time [101, 102, 103, 104, 105]. This unde-
sired formation of a glial scar changes the electrical coupling of the implant with
the surrounding tissue, but may even cause further damage as far as neuronal loss
caused by microglia entering in an overactivated state thereby releasing neurotoxic
reactive oxygen species. Ideally, an interface should ensure good electrical coupling
and while at the same time inducing stable and homogeneous neuronal network for-
mation whereas the formation of glial scar leads to a deterioration and loss of the
electrophysiological signal over time [106, 107, 14].
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2.3.3 Calcium Imaging
Ca2+, as discussed above, is an ubiquitous intracellular messenger and present in
many eukaryotic signal-transducing pathways, but also plays a central role in cellular
pathophysiology. So it is important to monitor the dynamic changes of Ca2+-levels in
living cells with both, spatial and temporal, accuracy. One straight-forward approach
is calcium imaging, where changes in the level of intracellular Ca2+ ([Ca2+]i) are
monitored with the help of Ca2+-indicators and microscopic techniques. Indicators
for Ca2+-imaging are often a combination of a calcium chelator and a fluorophore.
The binding of Ca2+ leads to a change in the emitted fluorescence by changing the
intramolecular conformation of the dye [108, 109].
One of the most prominent dyes is Fura-2-AM, a ratiometric Ca2+-indicator (figure
8A). The acetoxymethyl (AM) ester form makes the dye cell permeant and allows the
loading of cells in a noninvasive way. Fura-2 emits at a wavelength of 510 nm regard-
less the presence of Ca2+. The fluorescence intensity shifts when excited from 340
nm to 380 nm upon Ca2+-binding. The ratio of the emissions at these wavelengths
is thereby directly related to the amount of intracellular Ca2+ [110]. Another type
of dyes that is widely used in neuroscience is Fluo-4-AM (figure 8B). It is excited
at a wavelength of 488 nm and emits at 516 nm upon Ca2+-binding. It shows no
accompanying spectral shift upon Ca2+-binding, whereas the the fluorescence inten-
sity increases about 100 times, providing an optimized signal-to-noise ratio (figure
8C) [29, 111].
Figure 8: Chemical structure of the Ca2+-indicators (A) Fura-2 [112] and (B) Fluo-4 [113]. (C)
False colored fluorescence images of astrocytes loaded with Fluo-4. Arrows indicate promi-
nent changes in intracellular Ca2+-levels during the recording period (blue: basal levels, yel-
low/red increased levels; pictures taken by Saskia Karges).
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2.4.1 Properties of organic materials
Neural interfaces are devices built to exchange information with the nervous system.
A variety of (potential) implants are currently used in clinic or under trial in animal
models with the goal of improving the quality of life for individuals by restoring their
impaired physical, psychological or social functions [101, 114]. Basic neural interface
implants already play important medical roles, still research needs to be done to
fine-tune for example size, shape, or mechanical properties to enable chronic, stable
recordings or (selective) stimulation of neural activity [115].
In order to enable the interfacing of living tissue with any kind of material or
device, general criteria regarding the needs of the cells as well as the desired material
properties must be met. A summary of these requests is shown in figure 9.
Figure 9: Challenges in developing novel organic neural interface materials. The needs of the
living tissue has to be met, therefor the used materials must be biocompatible and biofunc-
tional. The choice of substrate depends on the application and must have the desired optical
and electrical functionality but also the stability to perform in the rather harsh biological
environment. Most of materials require a treatment with adhesion molecules, causing an
increased cleft between the living tissue and the interface. (modified from [116])
To ensure the adhesion and growth of cells, the material must be biocompatible
- thereby not having toxic or injurious effects on the living tissue as well as bio-
functional, which describes the ability of a device execute its intended function in
intimate contact with living tissue [117]. These questions have to be addressed and
the reason is straight forward: many materials applied for neural recording and stim-
ulation were not originally developed for neural interfaces. To allow adhesion and
growth of cells, materials need to have an homogeneous and unfractured surface
combined with an appropriate surface wettability and polarity [116, 118, 117].
As discussed in section 2.3.2, rigidity and mechanical stiffness of implants tend to
damage surrounding tissue during insertion and due to arising mechanical forces.
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In case of brain implants, the formation of a glial scar has to be avoided at any
costs. Traditionally, electronic devices were silicon or metal based, so called ’inor-
ganic’ materials that are characterized by a certain stiffness, non-transparency while
being at the same time stable and highly conductive. On the other side of the chemi-
cal spectrum, the organic materials can be found, a chemical term classically referring
to carbon-based compounds [14, 101, 96]. Those organic materials come in a broad
range of forms, from crystals all the way to disordered composites, polymers or even
gels and many of them have been found to display desired key features such as
biodegradability, softness, flexibility and conformability [119, 120]. Organic materials
are easily modified in their structure with the almost unlimited possibilities of chem-
ical fine-tuning. By changing for example the side-groups of a molecule, relevant
properties such as their topography, biocompatibility or mechanical stiffness can be
altered. A very important feature is the relatively low temperature (in comparison
to silicon based materials) at which organic materials can be processed - they are
often held together by weak molecular interactions which can be easily overcome by
mild heating [121]. Another important characteristic is that many organic materials
are very colorful, thereby interacting with light, making them interesting for example
light emitting diodes or organic solar cells. Other organic materials are transparent
or semi-transparent, this being the reason why they are of particular interest for ap-
plication in tools, where optical read-out techniques such as microscopy are used
[122, 123].
2.4.2 Organic semiconductors
Apart from the chemical classification in organic or inorganic materials, materials
can also be classified according to their conductance: conducing materials, which are
often metals and insulating materials. Some of the latter can be made conducting by
heating, illumination or enclosure (= doping) of small impurities (= dopants). The
resulting conductive materials are called semiconductors [9] and the most famous
among them is silicon. A pure silicon crystal is a good insulator, however doping
it with small amounts of phosphorus makes it conducting due to the fifth valence
electron - which serves as a free charge carrier (figure 10A). Those materials, whose
semi-conductance is based on introduced free electrons (negative charges), are called
n-type or n-doped. In contrast, using a 3-valent dopant such as boron makes electrons
in the valence band of the silicon mobile (figure 10B). These semiconductors are called
p-type semiconductors or p-doped, due to the positive ’holes’ [124].
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Figure 10: (A) N-type silicon doped with phosphorus. The donor impurity contributes free
electrons, increasing the conductivity. (B) P-type silicon doped with boron. The acceptor
impurity creates a so called hole. (modified from [125])
Many organic organic compounds can be made semiconducting by doping or are
semiconducting by themselves due to their chemical structure. Improvements in car-
rier mobility can be achieved either by an endless variety through chemical modifi-
cation towards better characteristics or by creating hybrids of organic and inorganic
materials [126, 127]. When building electronic devices with organic semiconductors,
only very thin layers of material are needed, making them flexible. Moreover they
tend to be rather soft than porous so they are bendable without breaking. This is par-
ticularly advantageous when it comes to building interfaces for in vivo applications,
where it is highly unlikely to find a straight and stark surface. In addition, many
of these materials can be produced by standard semiconductor fabrication processes,
such as printing, and can be processed at rather low temperatures and without much
energy usage [13, 14]. A non-exhaustive list of processing and device fabrication tech-
niques can be found in section 2.5.1.
Taken together, organic materials bear great advantages over inorganic materials.
They are extremely versatile and modification with the full toolkit of chemical pos-
sibilities offers an unheard possibilities of fine-tuning to create novel materials with
application-tailored properties, even though their conductivity is still a weak point.
Below, some of the most prominent and promising organic materials are introduced.
2.4.3 PEDOT:PSS
Many new daily life applications require flexible electrodes, preferably produced
with low-cost approaches. Devices that are supposed to be interfaced with delicate
tissue of the human body require conformability and flexibility, also from their elec-
trodes. To date, the material of choice for fabricating transparent electrodes is indium
tin oxide (ITO). However this substrate’s flexibility decreases with improved conduc-
tivity. Doping with silver can circumvent this disadvantage but only at the price of a
loss of transparency [128, 129].
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Figure 11: Chemical structure of Poly(3,4-ethylene dioxythiophene) (PEDOT, top) doped with
negatively charged poly(styrene sulfonic acid) (PSS, bottom, modified from [125])
Promising candidates for flexible and transparent electrodes were found in con-
ducting polymers, which display apart from their mechanical flexibility also tun-
able properties via chemical synthesis and superior optical transparency. Among the
most used conducting polymers, in particular in bioelectronics, is Poly(3,4-ethylene-
dioxythiophene) (PEDOT). PEDOT can conduct ions and undergo electrochemical
switching. PEDOT itself is a water-insoluble polymer, but by using the water-soluble
poly(styrene sulfonic acid) PSS as the charge-balancing dopant, PEDOT:PSS becomes
a stable and water soluble polymer mixture (figure 11) [130]. P-doped PEDOT with
PSS is well processable and shows an enhanced conductivity up to 10 S cm−1. The
conductance can be further increased more than two orders of magnitude by adding
secondary dopants to the PEDOT:PSS dispersions, such as different organic com-
pounds like diethylene glycol or dimethyl sulfoxide [131, 132]. The commercially
available PEDOT:PSS aqueous dispersion is a deep-blue solution. Films of PEDOT:PSS
have a good photo- and electrical-stability in air and can also be heated up to 100◦C,
without loosing their conductivity. These films are absorbing well in the visible light
range, allowing applications in energy conversion and storage devices, organic so-
lar cells, supercapacitors or thermoelectric devices. PEDOT:PSS can be processed by
a variety of techniques, from spin-coating to spray deposition up to printing. The
resulting continuous thin films on many type of substrates are smooth with a low
surface roughness, making them also favorable materials to be interfaced with living
tissue [133, 134, 125, 135, 136]. A device using PEDOT:PSS as the semiconducing layer
is introduced in section 2.5.4.
2.4.4 Perylene-derivatives
Perylene derivatives are molecules based on perylene, which is a poly-cyclic aro-
matic hydrocarbon with the chemical formula C20H12. They belong to a group of so
called small organic molecules which display interesting alterable physical, optical
and electrical properties. Perylene derivatives, often red, violet or black shaded, have
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been used as pigments and dyes for textiles [137]. They are chemically, thermally and
photo-chemically stable. They have been used in organic solar cells mainly as elec-
tron acceptor materials, because they absorb optically in the visible to near-infrared
spectrum, which allows a good "harvesting" of sunlight [138].
Perylene Tetracarboxylic Diimide derivatives belong to the most promising small
molecules to fabricate n-channel organic thin film transistors (OTFTs) [139]. These
particular perylene derivatives display uncommon n-type transport characteristics
due to their strong electron affinity of the imide-groups, a large overlap of the pi-
electron system, favored by the molecule’s planarity and the presence of the alkyl-
chains, which enhance the overlap between the molecular orbitals of neighboring
molecules. These three factors taken together assume responsibility for field effect
charge transport and the optical properties [14, 13].
p13 - an n-type semiconducting perylene derivative In particular N,N0
-ditridecyl perylene-3,4,9,10 tetracarboxylic diimide (P13) [140] was found to be one
of the most favorable candidates of n-type perylene based semiconductors in biologi-
cal applications. It’s specific chemical structure is displayed in figure 15. In addition to
its electronic properties, another advantage of P13 is its transparency. The hydropho-
bicity of P13 can be seen as a disadvantage in interfacing this material with living
tissue, for it has a contact angle of 97.9 ± 1.6◦, which is rather high in comparison
with PDL- and Laminin-coated glass (53.4 ± 2.5◦) [14].
Figure 12: Chemical structure of N,N’-Ditridecylperylene-3,4,9,10-tetracarboxylic diimide
(P13, modified from [140]) Marked in bold is the perylene backbone of the molecule.
In a study of our group, P13 thin films have been shown to be stable upon exposure
to cell-culture media without significant changes in their morphological, structural
and photophysical features. The same study showed that primary sensory DRG neu-
rons from post-natal rats remained viable for many days on PDL-laminin coated P13.
Those cells showed neurite outgrowth and their excitability properties resembled
those of neurons grown on control PDL-laminin coated glass [14].
2.4.5 Thiophenes
Thiophenes are a class of molecules, based on thiophene, also commonly called thio-
furan, which is an aromatic flat heterocycle with the formula C4H4S (figure 13A).
Thiophenes linked with each other to form a polymer are called oligo- and polythio-
phenes (figure 13B).
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Figure 13: (A) Chemical structure of thiophene. (B) Chemical structure of polythiophene.
From the chemical point of view, thiophenes are stable, easy to process and pre-
destined for modification: at the sulfur atom or at the carbon-ring, a broad range of
functionalizations are possible, allowing an extreme fine-tuning of the desired prop-
erties. Upon partial oxidation, polythiophenes become electrically (semi-) conductive,
making them attractive for integration in electronic devices [141, 142, 143].
Some thiophene oligomers show interesting fluorescence properties, making them
valuable materials as active components for applications in light-emitting diodes
(LEDs). By attaching different functional side chain substituents bright stable light
emission ranging from blue to near-infrared have been realized [144].
Another important field is the integration of oligo- and polythiophenes in optical
sensors. One possible application is the detection of various biomolecules such as
DNA, RNA, ions or proteins and is also useful in the high-throughput screening of
new drugs. Moreover the detection of specific DNA-sequences is crucial for genetic
analysis to diagnose various genetic diseases. Novel tools are urgently needed here to
skip chemical amplification steps, such as the polymerase chain reaction, for a more
rapid assessment [145, 146].
In highly specific DNA-sensors, polythiophenes play already an important role.
Such a system consists of two components: a fluorophore labeled single-stranded
oligonucleotide capture probe and a cationic polythiophene. The latter serves as a
donor for fluorescent energy-transfer, causing a desired signal amplification. The
detection mechanism is based on the conformational change of the polythiophene,
when interacting with single- or double stranded DNA [147]. A buffered solution
with the pure polymer may appear yellow, when interacting with single-stranded
DNA red (forming a duplex) and return to yellow, when the single-stranded DNA
hybridizes to double-stranded DNA when the complementary strand of the capture
probe is added (formation of a triplex). Each change in the thiophene conformation is
accompanied by a shift in the absorption spectrum. In case of mismatches of the com-
plementary strand with the capture probe, the absorption will differ from a perfect
match [148, 149].
p3ht-pcbm One well-studied thiophene blend is P3HT:PCBM, consisting of the
conducting polythiophene poly(3-hexylthiophene) (P3HT) and the fullerene deriva-
tive [6,6]-phenyl C61-butyric acid methylester (PCBM, figure 14A).
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Figure 14: (A) Chemical structure of the P3HT:PCBM blend. Left: poly(3-hexylthiophene)
(P3HT), right: [6,6]-phenyl C61-butyric acid methylester (PCBM). (B) Schematic represen-
tation of charge separation in a bulk heterojunction device. The created free charges flow
through the layer where they are created in to the respective electrode (modified from [150]).
It has to be highlighted that such a blend isn’t a homogeneous mixture of two
materials, but a so called bulk heterojunction, where the two materials with different
electrical properties are forming microdomains in the order of nanometers (figure
14B). This is creating a large interfacial area [151, 152].
P3HT:PCBM, because of its good light absorption, is widely used in organic so-
lar cells, whose function is based on an electron donor-acceptor mechanism. In case
of P3HT:PCBM, P3HT is more electron rich and serves as the electron donor, while
PCBM plays the role of the electron acceptor. When now exciting the blend with
light, light is absorbed and excitons (bound electron-hole pairs), which are split into
free charge carriers at the donor/aceptor interface, are created. The donor thereby
becomes negatively, the acceptor positively charged. The resulting electron is trans-
ported through the acceptor layer towards the electrode. The probability of charge
separation is maximized by the blend’s large interfacial area while at the same time
the recombination process is limited [153, 154]. P3HT based solar cells have a power
conversion efficiency exceeding 3-5%, the focus in the organic solar cell research lies
on increasing this efficiency, mostly by doping one of the organic components or by
changes in the fabrication process, e.g the annealing temperature [126].
Another application, where a broad absorption in the solar spectrum is highly de-
sirable, are retinal prosthetic devices. The idea behind is to couple electronic sensors
for example with neuronal tissue to translate information carried by light into elec-
trical activity and communicate this information to neurons. P3HT:PCBM was found
to be a promising material, not only for its optical and electrical properties, but also
for its biocompatibility and "soft" organic nature to create flexible interfaces. A very
particular hybrid organic device with P3HT:PCBM as semiconducting layer, realized
by Ghezzi et al. is described in section 2.5.5 [152, 155].
2.4.6 Biomodified organic materials
To date, most approaches interfacing organic semiconducting materials or devices
with neural cells still required a treatment of the material’s surface with cell adhesive
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proteins from the extracellular matrix (such as poly-lysine, fibronectin, collagen or
laminin). However, the use of these proteins bears some disadvantages. On one hand
it has been discussed that surface coating, by increasing the cleft at the interface of
cell and transistor, could cause a decrease in the recording sensibility of the respec-
tive organic devices (see figure 9) [118, 156, 10, 100]. Moreover, protein degradation
over time due to cellular proteolytic activity is a crucial issue, making a long-time ap-
plication in vivo impossible. Another non-trivial step is the isolation of these proteins
from other organisms and their purification, which an can lead to infections, immune
responses and, in case of brain implants, to gliosis [105].
In neuronal tissue culture, poly-L-Lysine is one of the most commonly used sub-
strates. It enhances cell attachment to various substrates by means of its positive
charge that interacts with the anionic sites of the plasma membrane [157].
t4lysine Oligothiophenes based on quaterthiophene (T4) have already been used
as functional semiconducting material for the realization of organic devices, mainly
for their high carrier mobilities and well defined length [158]. The chemistry behind
has been well established over the past years [159]. But casted T4 alone doesn’t meet
the requirements for cell adhesion, because it forms large rhomboidal crystals instead
of films and is thereby due to its roughness not suitable to be interfaced with cells
[118]. To combine the optical and electronic features of T4 with the established cell ad-
hesion and growth functionalities of Poly-L-Lysine, T4 was covalently functionalized
to the L-Lysine-ended quarterthiophene T4Lys to become the first of biomodified
organic materials [160].
Figure 15: Chemical structure of T4Lysine (T4Lys, modified from [160]) Marked in bold is the
tetratiophene (T4) backbone of the molecule.
The results of the biocompatibility study and the electrophysiological characteri-
zation of DRG neurons interfaced with T4Lysine are described in chapter 4 of this
thesis.
pdi-lys As described above, the perylene diimide derivative P13 has already been
successfully tested as a platform for DRG neurons, even though its hydrophobicity
is a disadvantage in terms of cell adhesion. In order to create a suitable interface, the
material had to be coated with PDL to circumvent this issue. With the realization of
T4Lysine, where lysine was directly integrated into the organic molecule, the addi-
tional coating step could be skipped. The same strategy was used to create a perylene
diimide derivative bearing lysine groups to combine the properties of lysine to sup-
port neuronal adhesion, growth and differentiation with the n-type semiconducting
properties of perylene diimide.
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Figure 16: Chemical structure of PDILys (T4Lys, modified from []) Marked in bold is the
perylene backbone of the molecule.
It was shown that the lysine-functionalization decreased the high hydrophobicity
found in P13 thin- films. In turn also an improved cell adhesion was found with
PDI-Lys which is also supporting DRG neuron differentiation. the higher neurite
length on PDI-Lys was attributed to the soft nature of this novel organic material, the
enhanced in vitro biocompatibility to the introduction of lysine [161].
These two example of lysine-functionalized organic materials are promising mile-
stones on the way of finding suitable materials for bio-electronics targeted to neu-
ral engineering applications, while skipping the additional coating steps by tailored
chemical synthesis.
2.5 organic bioelectronic devices for electrophysiological appli-
cation
Organic electronics is a relatively young scientific field that developed over the past
two decades. This technology, even though the realized devices are still inferior in
terms of performance, aims to replace the classic inorganic semiconductor devices.
The reason are the advantageous properties such as their lower price (they are
much cheaper than silicon), flexibility and transparency. They play already a role in
solar cells and organic photovoltaics, being again much cheaper than their silicon-
based counterparts. Also organic light-emitting devices and field-effect transistors
are already well-developed and partly already commercialized [162, 163].
2.5.1 Device fabrication techniques
One of the advantages that comes with the use of organic materials is the variety of
device fabrication methods that may be used, whereas inorganic materials are limited
to just a few. This section is intended to give a brief overview of some of the currently
most used fabrication techniques.
Physical vapor deposition (PVD) PVD is the term to describe a variety of vac-
uum deposition methods which can be used to produce thin films. For PVD, the
substrate to be coated is placed inside a vacuum chamber where it is exposed to
precursors that are vaporized by physical techniques (such as heating or sputtering).
This vapor begins to condense onto the substrate material and form a uniform layer.
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By adjusting the temperature and duration of the process the thickness of the coating
can be controlled. For polymer deposition, the monomers are introduced into the
chamber, where they react with each other when depositing onto the substrate sur-
face. For metallic compounds, the heated vapor is condensed onto a cooler substrate
surface [164].
Chemical vapor deposition (CVD) Just like PVD, in typical CVD, a substrate is
exposed to volatile precursors. In principle, a heated substrate surface is exposed to
the vaporized coating material. By chemical reactions occurring on the hot surface,
a solid component is deposited as a thin film from the gas phase onto the substrate
[165].
Spray deposition For spray deposition, molten metal is gas atomized and the
spray is caused to hit the substrate while being still in the liquid or semi-solid state
and a layer of dense solid metal of a predefined shape is sublimed [166].
These traditional methods, also used to process inorganic materials, generally require
a high vacuum and high temperatures, consuming thereby a lot of energy which
makes them costly. With organic materials, solution-based preparation methods come
into play, which are carried out at room temperature or moderate temperatures and
atmospheric pressure. By the choice of the fabrication technique, some of the prop-
erties of organic materials may also become tune-able. For example to optimize the
charge carrier movement of organic materials, their morphology can be adapted by
the use of different solvents. A solvent with a higher boiling point may lead to more
crystalline structures, for it needs more time to evaporate [167, 121]. Following is a
non-exhaustive list of commonly used fabrication techniques for organic materials.
Etching methods Etching is used to remove layers selectively from a substrate
surface in order to create patterns. Before etching the pattern is defined by an etching
mask to protect the parts of the material, which should remain. Dry etching with
plasma is used for circuit-defining steps, while chemical (=wet) etching is used to
clean substrates. Plasma etching is one of the most used processes in semiconductor
manufacturing [168].
Spin-coating Spin coating is used to deposit uniform films onto flat substrates.
Therefor a small amount of material dissolved in a volatile solvent is applied to the
center of the substrate. Then the substrate is rotated at high speed and the majority
of the deposited is flung off the side by centrifugal force, leaving the substrate with
a highly uniform film from a few nanometers to a few microns in thickness. The
advantage of spin coating is its ability to produce very uniform films in short time
[169].
Inkjet printing The same technology that is used in customary office printers can
be used to print soluble polymers or nanoparticles on a broad variety of substrates,
ranging from glass to paper [170].
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Screen Printing A method of choice to fabricate conductive connections between
electronic components. First a print pattern is created on a mesh surface. This screen
mask is placed on top of an alumina substrate, a paste or ink is then applied on top
of the screen and then the paste scraped over the mask by a squeegee, transferring
the pattern onto the substrate [171].
2.5.2 OFETs and the O-CST
Transistors in general are the fundamental element in modern circuitry; they are used
as either signal amplifiers or on/off switches. An organic field effect transistor (OFET)
consists of a sandwich-like structure of gate, dielectric, the organic semiconducting
layers and two metal contacts (source and drain electrode) that are electrically con-
nected to the semiconductor. OFETs can be fabricated in different configurations as
shown in figure 17.
Figure 17: OFETS can be fabricated in different configurations. (A) Top-gate, bottom contact,
(B) top-gate, top-contact, (C) bottom-gate, top-contact and (D) bottom-gate, bottom-contact
(modified from [172]).
When a voltage is applied between the source and the gate electrodes, an elec-
tric field normal to the device surface will build up in the semiconductor, attracting
charge carriers at the semiconductor-insulator interface (figure 18B). Operating an
OFET in this way is called accumulation mode. When additionally applying a posi-
tive voltage between the source and drain electrode, a negative current flows across
the channel area from the drain to the source as displayed in figure 18C. In case of a
negative applied voltage, holes will flow from the source to the drain electrode, estab-
lishing a current through the semiconducting film (ISD). This current can be modified
by varying the applied voltages VGS and VDS [173, 172, 167].
An OFET can be used as a sensor for voltage changes on top of its channel, therefor
it is also "able to sense" e.g action potentials of neurons by the change of the ion flux at
the interface. This cellular electrical activity changes the electric field of the transistor
and by these means its output current [121].
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Figure 18: (A) OFET in bottom-gate, top-contact configuration without any voltages applied
(black wires). (B) A voltage is applied between the gate and the source (VGS) electrode
(red wires). A charge separation is taking place at the interfaces and an electrical field is
building up (accumulation mode). (C) An additional positive voltage is applied between
source and drain (VDS), resulting in a flux of negative charges from drain to source (black
dotted arrow). (modified from [167]).
an ofet as cell stimulating and sensing device The OFET (hereafter
referred to as O-CST, see figure 19) used in this work was first introduced in a
study carried out by my group in 2013, when DRG neurons were interfaced, stim-
ulated and their response recorded with this O-CST [13]. DRG neurons were chosen
for this study, because they are known to be almost electrically silent [174], which
makes stimulation-evoked activity distinguishable from the occasional spontaneous
firing. The O-CST device has a glass substrate coated with Indium Tin Oxide (ITO),
double serving as a bottom gate electrode and mechanical support. As a transpar-
ent dielectric polymethylmethacrylat (PMMA) was used and P13 (as introduced in
section 2.4.4) serves as the n-type semiconducting material. The source and drain
electrodes are made of gold and are covered by an additional capping layer of P13
that acts as an insulator to avoid direct contact between the tissue culture medium
and the electrodes. The distance between the two electrodes (=channel width) is 70
µm. To prevent also the evolvement of Faradaic currents in contact with tissue cul-
ture medium, the maximal voltage applied on the device in biological studies is 1
V [13]. In a first step of the study the P13, the material of the capping layer, coated
with PDL and Laminin was found to allow adhesion and growth of primary DRG
neurons (see figure 20A) and the presence of neurons was confirmed by staining
for neuronal nuclear protein (NeuN) and growth-associated protein 43 (GAP-43), a
neurite outgrowth marker (figure 20B and C respectively).
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Figure 19: Schematic representation of the O-CST with a P13 capping and semiconducting
layer (red), source and drain electrodes made of gold (Au, yellow), the dialectric made of
PMMA (grey) and the ITO gate electrode (blue). The whole device is build up on a glass
substrate (reprinted with permission from [13], Copyright 2016, Nature Publishing Group).
Figure 20: (A) Micrograph of DRG cultures on P13 thin films after 7 days in vitro. The arrow-
head indicates a neuronal cell body, the arrow depicts neurite extension. (B) LSCM image of
P13-plated DRG cells, stained for NeuN. (C) LSCM image of P13-plated DRG cells, stained
for and GAP43 (reprinted with permission from [13], Copyright 2016, Nature Publishing
Group).
The researchers then performed a computational study about the electric fields
and electrostatic potentials when applying voltages to the electrodes to have a first
guess about the effect on DRG neurons. Also field effect transistors like the O-CST
can be operated in accumulation mode with the source grounded. When applying
a small positive voltage (1V) at the gate electrode (VGS), the capacitor is charged at
the dielectric-semiconductor interface and an electric field is built up. Computational
simulations showed that the electrostatic potential is null above the electrodes and
about 0.7 V in the region above the channel (see Fig.21A). This value was assumed
to be sufficient to evoke a capacitative depolarization of neuronal cells, because it is
able to induce a relatively large potential in a localized region of space. A regular
increase of VGS over time is thus potentially able to realize a steady variation of the
potential at the organic-solution interface from 0 to about 0.7 V.
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Figure 21: 2D simulation plots of the electric field (vectors) and electrostatic potential (color
scale) in the capping layer of the O-CST for different biases. (Reprinted with permission
from [13], Copyright 2016, Nature Publishing Group).
When VDS=1V and VGS=0V (see figure 21B) the intensity of the electric field was
predicted as not constant along the channel length, resulting in a less intense field.
Cells on top of the channel were expected to be exposed to a varying charge distribu-
tion along the channel, with an excess of positive charges in correspondence to the
cleft - promoting a hyperpolarization of the neuronal membrane voltage.
When additionally applying a source-drain voltage (VGS=1V, VDS=1), the electric
field distribution remains asymmetric, with an induced almost constant and positive
electrostatic potential at the capping layer interface (figure 21C). Here an induced
depolarization of the cell membrane was expected due to a negative ionic charge
layer in the cleft between the cell membrane and the device surface.
The group of Valentina Benfenati performed also experiments to study the simul-
taneous recording and stimulation from O-CST. To this end, they first performed ex-
periments stimulating with the O-CST applying the stimulation protocols described
above, while recording the cellular response by performing whole-cell patch-clamp
in current-clamp mode (figure 22). When giving a pulsed stimulation after a control
recording period, they were able to detect spikes resembling action potentials, when
the O-CST bias was around 800 mV (figure 22A). When using a constant VDS of 1V
and biasing the gate with a ramp from 0-1V, they observed a hyperpolarization of the
membrane potential (as expected from the computational simulation) followed even-
tually by an action potential (figure 22B). By evoking action potentials by the means
of a current-step stimulation protocol applied to the cell via patch-clamp, the possi-
ble use of the O-CST as a sensor was tested. They correlated the given stimulation
and the so evoked action potentials with the extracellular recording by the O-CST.
Even though the recorded signal was rather weak and noisy, they could demonstrate
the O-CSTs ability to record from a single neuron (figure 22C-E). To compare the
obtained results directly with the technology currently available on the market, the
researchers coupled the output of the O-CST drain electrode with the amplifier and
recording electronics of a MEA System (figure 23, see also section 2.3.2). They found
that the O-CST device had an improved signal-to-noise ratio with respect to the MEA
system by a factor of 16 on the same neuronal preparation. The attributed this to the
efficient coupling between the organic semiconductor and the cells.
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Figure 22: Patch-clamp experiments performed on DRG neurons seeded on the channel of
the O-CST. (A) Current-clamp trace recorded before and during pulsed O-CST stimulation
(protocol see upper inset). The dashed line indicates a zoom-in to highlight the action po-
tential profile. (B) Current-clamp trace recorded upon continuous ramp stimulation by the
O-CST (protocol see upper inset). A zoom-in (*) highlights the action potential profile. (C)
Patch-clamp stimulation protocol consisting of a family of increasing current steps of 25 pA
from 200 to 400 pA for 100 ms. (D) Patch-clamp trace recorded with the stimulation proto-
col of (C). (E) The evoked action potentials by stimulation with current steps in (D) were
simultaneously recorded by the O-CST. Red stars indicate the detected spikes by off-line
data analysis with custom software (reprinted with permission from [13], Copyright 2016,
Nature Publishing Group).
Figure 23: (A) Extracellular signals recorded by the O-CST upon applying a bias to the de-
vice with a pulsed stimulation protocol as depicted by the inset (VDS=0V, VGS=0-1V). (B-C)
Respective zoom-ins highlighted by the asterisk in (A) and (B) respectively (reprinted with
permission from [13], Copyright 2016, Nature Publishing Group).
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2.5.3 EGOFETs
An electrolyte-gated organic field effect transistor (EGOFET) device is is a three-
terminal field-effect transistor (FET) device comprising gate, source, and drain elec-
trodes. The source and drain electrodes are separated by a region called the channel,
which is build up by an organic semiconducting layer deposited between them. The
difference between an EGOFET and a conventional OFET is the use of an electrolyte
as gate insulator instead of a dielectric layer [175]. When applying a bias between the
gate electrode and the grounded source, confined electric double layers are formed
at the interface between the semiconductor and the electrolyte and the electrolyte
and the gate. This process reaches a steady state, where the driving force for ion
migration in the electrolyte layer is eliminated. The equivalent circuit of an EGOFET
can be modeled as two capacitors in series, representing the two electric double layer
interfaces.
Figure 24: (A) Schematic representation of EGOFET (modified from [176]) (B) EGOFET with a
modified organic semiconductor (here P3HT) to serve as a biosensor. A monoclonal antibody
layer is physisorbed on the organic semiconducting layer, in presence of the antibody’s target
analyte an electrical response can be measured (modified from [177]).
An EGOFET can be transformed into a bio-sensor when anchoring recognition
tools, such as antibodies or enzymes, onto one of these interfaces. This additional
layer can be seen as an additional capacitor in the system. The capacitor of the bio-
logical layer is smaller than the other two and thereby highly sensitive to detecting
changes in the bio-layer upon for example binding of a ligand (e.g the respective
substrate of an enzyme or the specific target to the antibody). Due to this sensitivity
and the possibility to detect both, charged and neutral ligands, EGOFETs are among
the most promising devices for electronic biosensing applications [163].
In 2013, Cramer et al. introduced a liquid gated transistor as an interface for the
recording and stimulation of neuronal cells (figure 25A) [178]. The semiconducting
layer in this EGOEFT consisted of a pentacene film with a terraced morphology which
was found to be biocompatible with murine neural stem cells for up to two weeks.
By fine-tuning of the pentacene film properties, they were able to improve cell ad-
hesion without adding an additional coating layer of extracellular matrix proteins.
By these means, the group was able to reduce the cleft between the cells seeded on
top and the actual device, expecting the capacitive coupling between the semiconduc-
tor and cells to be maximal due to direct contact. Murine neural stem cells on top of
functional device were then differentiated into neuronal networks and during the dif-
ferent phases of neuronal differentiation, the OFET response was monitored (figure
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25B). To this aim, a possible response of the neuronal population on the device was
triggered by a voltage stimulus applied through the gate electrode (figure 25C). Only
after the differentiation of the stem cells into interconnected neurons, they were able
to measure electrical signals in the OFET current where the liquid-gated pentacene
transistor transduced the electrostatic potential at the interface between the channel
and the electrolyte.
Figure 25: (A) Schematic representation of the liquid gated transistor. The dashed arrow in-
dicated the current from the source to the drain electrode, which results from the average
change in the potential at the cleft caused by the cell activity (modified from [178]). (B)
Raw data trace showing the IDS current drift and the stretched exponential fit (dashed line).
(C) Stimulation pulse shape applied to the potential between the source and the gate elec-
trode. (D) Absolute current traces measured after stimulation with different intensity. (E)
Histogram of the current noise with their Gaussian fit (continuous lines) after stimulation.
(reprinted with permission from [178], Copyright 2016, Royal Society of Chemistry).
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In their study, the authors highlight that their device has a rather large area (0.2
mm2) averaging the response of several hundred or thousand cells forming a neu-
ronal network. Therefor its working principle cannot be seen as suitable for the
detection of action potentials, or even the recording of single cells. Another disad-
vantage can be seen in the short durability of the device, which could operate with
good response in tissue culture medium for up to nine days. A long term electro-
physiological application is therefor excluded with this device’s setup.
2.5.4 OECTs
Organic electrochemical transistors (OECTs) are three terminal devices in which the
source and the drain electrodes are connected by a conducting polymer. The gate
electrode is separated by an electrolyte from this polymer layer. The operation of
an OECT is based on the doping and de-doping of the conducting polymer, which
modifies the polymer’s conductivity. Nowadays the most used conducting polymer
is PEDOT:PSS (see also section 2.4.3). When no gate-voltage is applied, this polymer
is conducting. When applying a bias at the gate, cations from the electrolyte solu-
tion enter the polymer bulk to compensate the negatively charged sulfonate moieties
of the PSS. The result is a decrease in the hole density, and as a consequence a de-
crease in the polymer conductivity because only a lower current can flow through
the channel [162]. In this way, an OECT device is capable of converting an ionic cur-
rent into an electronic one. Taken together with the possibility of operating an OECT
at low voltages (below 1V), which allows an operation in aqueous medium without
introducing Faradaic currents, makes an OECT a favorable tool to monitor biological
phenomena. One of the first application of an OECT at the interface with biology was
the use as an enzymatic sensor, followed by applications as ion, nucleotide and other
macromolecules sensors [179].
Figure 26: Schematic representation of the OECT used in the study of Malliaras et al. in 2013.
The array is embedded in parylene, which provides a flexible the device. The semiconduct-
ing layer is made of PEDOT:PSS and the source and drain electrodes of gold (modified from
[180]).
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As described above in section 2.3.1, electrophysiological signals are generated by
ionic currents and cells can be subdivided into excitable (neurons, cardiomyocytes
etc.) and non-excitable cells (such as astrocytes). Theoretically OECTs would provide
an optimal system to directly convert ionic currents from living tissue into electronic
ones.
Figure 27: (A) ECoG probe placed over the somatosensory cortex of an anesthetized rat. (B)
Electrical circuit of the OECT, the gray box indicates the brain of the rat. (C) Bicuculline-
induced epileptiform spike recorded from a transistor (pink), a PEDOT:PSS surface elec-
trode (blue) and 12 Ir-penetrating electrodes (black). (D) Recordings from an OECT (pink), a
PEDOT:PSS surface electrode (blue) and an Ir-penetrating electrode (black). (Reprinted with
permission from [180], Copyright 2016, Nature Publishing Group)
Currently in clinical use for the brain are three electrophysiological recording tech-
niques: electroencephalography (EEG) with electrodes getting attached to the pa-
tient’s skin, electrocorticography (ECoG) where electrodes are placed on the surface
of the brain, and stereoelectroencephalography (SEEG) where probes are inserted
deep into the brain [179]. However in 2013, the group of Malliaras reported for the
first time in vivo electrophysiological recording of brain activity with an OECT [180].
The array was embedded in an ultra-thin film of patterned parylene, providing a
highly flexible and conformable device, optimal for the brain surface. The semi-
conducting layer consisted of PEDOT:PSS and the integrated electrodes of gold. A
schematic representation is shown in figure 26. This ECoG probe was then placed
on the somatosensory cortex of an epileptic rat. By perfusing the GABAA-receptor
antagonist bicuculline on the surface of the brain, they evoked a seizure-like spiking
activity. In comparison to surface PEDOT:PSS microelectrodes and control penetrat-
ing electrodes, they reported a better signal-to-noise ratio, which they attributed to
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the local signal amplification through the OECT. The obtained electrophysiological
signal was described as similar to the one obtained with penetrating electrodes.
Due to the possibility to directly convert ionic to electric currents, together with
the good biocompatibility, flexibility and the good signal-to-noise ratio, the OECT
represents currently one of the most promising devices for extracellular electrophys-
iological recording. It is also imaginable that even slight changes in the membrane
potentials of unexcitable cells like astrocytes might be recorded with an OECT. Still,
one of the drawbacks of the OECT is the reference electrode and the counter electrode
used in the measurements, which is an obstacle in miniaturization and still remain-
ing bulky [181]. Moreover the PEDOT:PSS semiconducting layer tends to degrade
rather quickly in the harsh biological environment, making the the OECT unsuitable
for long term recordings.
2.5.5 Hybrid biointerfaces
Another important application for organic materials in bioelectronic interfaces is the
realization of retinal prosthetic devices. Again the soft nature of the materials come
into play, but also a reliable transduction of the information carried by light into elec-
trical activity to be transferred in visual information processing networks is a crucial
point. Organic semiconductors were described to be capable of closely reproducing
the color response function of the human retina [155, 152].
In 2011, Ghezzi and others reported on the functional interfacing of an organic
semiconductor with a neuronal network and demonstrated photostimulation of neu-
ronal activity with visible light [155]. The active layer of the interface consisted of
the polymer-blend P3HT:PCBM that was introduced in section 2.4.5, together with
the working principle of a bulk heterojunction. As described above, P3HT works
as the electron donor, whereas PCBM is the electron acceptor. The authors found
ITO/P3HT:PCBM treated with PLL to be biocompatible with primary hippocampal
neurons. Also the physiological properties of hippocampal neurons cultured on the
material were evaluated with the patch-clamp technique and all evaluated parame-
ters (Vmem, frequency and amplitude of spontaneous excitatory currents, firing rate)
were found to be similar in comparison to control that consisted of ITO-coated glass
with PLL.
To investigate whether the light efficacy would trigger neuronal activity, they per-
formed whole-cell patch-clamp recordings under photostimulation (figure 28A, B).
The authors were able to elicit spike trains with light pulses (20 ms at 1 Hz, figure
28C) with a percentage of failures below 15%. They found that when the stimulus was
hitting precisely the cell body, action potentials could be reliably evoked, whereas it
would be ineffective when it was placed beside the cell (figure 28D).
Even though a number of options were postulated, and the authors favored a
purely capacitive mechanism due to very low generated photocurrents, the trans-
duction mechanism remains unclear. The photostimulation was also stated as unspe-
cific for selected neuronal populations. However this approach, taken also together
with further studies of this group (see in particular Ghezzi et al. 2013 [152], where a
P3HT-based optoelectronic interface restored the light sensitivity in rat retinas with
photoreceptor degeneration), it can be said that promising opportunities are arising
for this type of devices to realize the goal of artificial vision.
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Figure 28: (A) Schematic representation of the photosensing interface. The neuronal network
is grown on top of the polymer layer for patch-clamp recording (B) Schematic representa-
tion of the localization of the optical stimulus in the patched neuron. (C) Action-potential
generated in response to the photostimulation pulse (50 ms) and spike train generated with
a pulsed photostimulus. (20 ms pulses with a frequency of 1 Hz, green trace). (D) Spatial
properties of the photostimulating interface. A grid of nine spots (diameter 20 µm, spacing
30 µm) was overlaid to a patched neuron and spikes were counted to exclude spontaneous
activity. The little histogram plots on the right side represent the spike counts per number
of sweeps in all recorded neurons. Each histogram represents spike count at the correspond-
ing stimulation spot (green circles in the left panel). (Reprinted with permission from [155],
Copyright 2016, Nature Publishing Group)
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Manufacturers of chemicals, buffers and tissue culture media are listed in the ap-
pendix.
3.1 cell culture
All primary cell cultures were prepared at the Department of Pharmacy and Biotech-
nology of the University of Bologna. All procedures and handling of animals were
performed according to procedures approved by the Ethical Committee for Animal
Experimentation of the University of Bologna. Every effort was taken to reduce the
number of animals and their suffering.
3.1.1 Astrocytes
preparation of astrocytes Neonatal rats p0 - p2 (Sprague Dawley) were sac-
rificed by decapitation. The head was cleaned with 70% EtOH, then fixed with a
sterile needle. The skin was opened at the midline of the head with microdissecting
scissors, cutting from the base of the skull to the mid-eye area. The skull was opened
at the midline fissure avoiding to cut into the brain tissue, then removed carefully
with forceps. The meninges were gently peeled off by tipping over the brain tissue
with sterile cotton swabs. With a scalpel, the cerebellum was cut off. With a spatula,
the two hemispheres were separated, then a shallow layer of each cortical hemisphere
was removed and transferred into 3 ml of tissue culture medium containing 15% FBS
(see table 1). The tissue was dissociated mechanically, using a micropipette and tips
with decreasing diameter, until the tissue was completely dissociated. The dissociated
cortex was then filtered through a nylon cell strainer. Afterwards, the cell strainer it-
self was rinsed with medium. The filtrate was transferred into a 25 cm2 tissue culture
flask and incubated at 37◦C, 5% CO2.
Two days after preparation, the medium was carefully changed to remove the de-
bris from preparation. Afterwards, every second day, the flasks were rinsed with pure
Dulbecco’s Modified Eagle Medium (DMEM) and shaken to remove debris and un-
desired cell types. The cells were maintained in medium containing 15% FBS (table 1)
After reaching confluence, astrocytes were maintained in culture medium containing
10% FBS (see table 1). After 2-3 weeks, astrocytes were re-plated onto the respective
substrates by enzymatical dispersion, using 0.25% trypsine-EDTA, seeded at the re-
quired concentration per substrate and maintained in culture medium containing 10
%FBS [182, 183, 184, 185].
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15% FBS 10% FBS
DMEM 84% (168 ml) 89% (178 ml)
FBS 15% (30 ml) 10% (20 ml)
PenStrep* 1% (2 ml) 1% (2ml)
Table 1: Medium for preparation and maintainance of primary astrocytes. Numbers in brack-
ets indicate the volume needed for the preparation of 200 ml. *penicillin-streptomycin (100
U/mL and 100 mg/ml respectively) [182].
3.1.2 Dorsal Root Ganglia
preparation of drg neurons Postnatal rats p7 - p21 (Spraugue Dawley) were
anesthetized with Halotane prior to decapitation. A midline incision was made along
the back with microdissecting scissors and the skin deflected laterally. The spinal
column was removed and cleaned from attached tissue with a scalpel. The spinal
column was then cut in half along the ventral side with a sharp scalpel, then pulled
apart and the medula was taken out. The DRGs were located under a dissecting
microscope in their small cavities along the lateral vertebral column and carefully
spooned out by microforceps in order not to squeeze them, then transferred into a
Petri dish with PBS (RT). With the scalpel any fibrous tissue surrounding the DRGs
and the attached nerve roots were cut under the dissecting microscope. Afterwards,
the ganglia were rinsed in an Eppendorf cup with PBS, then transferred into a Petri
Dish with DMEM containing 5000 U/ml type IV collagenase for 45 - 75 min at 37◦C, 5
% CO2, and then dissociated gently with some passages through 0.5 mm and 0.6 mm
sterile needles. Cells were washed by resuspension and centrifugation (960 rpm, 10
min) and then appropriately diluted in 1 ml of medium (see table 2). Cells were then
seeded onto the respective substrates as described in 3.2 and maintained in medium
completed with cytosine β-D-arabinofuranoside (ArAc, 1.5 mg/mL), a cytostatic that
to reduces glial cell expression, and nerve growth factor (NGF, 50 ng/mL; see table
2) [186].
DMEM 89% (44.5 ml)
FBS 10% (5 ml)
PenStrep* 1% (500 µl)
ArAc 0.1% (50 µl)
NGF 0.1% (50 µl)
Table 2: Complete medium for DRG neuron maintenance. Numbers in brackets indicate the
volume needed for the preparation of 50 ml. *penicillin-streptomycin (100 U/mL and 100
mg/ml respectively) [13].
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3.2 preparation of substrates
3.2.1 Coverslips
Glass coverslips were soaked in 70% EtOH at RT overnight, then dried under laminar
flow in a sterile hood.
3.2.1.1 Coating of coverslips for cellular adhesion
poly-d-lysine PDL (PLL accordingly) was diluted to a final concentration of 0.1
mg/ml in PBS. A drop to wet the whole coverslip was applied, then the substrates
were incubated for 20 min at RT. The drop was aspired and the coverslip rinsed three
times with sterile, distilled water.
laminin For neuronal cells, coverslips were first treated with Poly-Lysine as de-
scribed above. After the third washing step, the coverslips were incubated with
Laminin in PBS at a final concentration of 10 µg/ml for 20 min. The solution was
aspired and the coverslips rinsed three times with distilled sterilized water.
3.2.1.2 Deposition of organic materials on coverslips
t4lysine T4Lys was dissolved in distilled water to a concentration 1 mg/ml. 100
µl of solution was dropcasted on glass coverslips and left drying under laminar flux
for 3 h at RT. The thickness of the films prepared for experiments with cell culture
was measured by performing profile measurements on three different samples (Pro-
filmeter KLA Tencor) and it was 244 ± 38 nm.
p13 P13 thin-films of the respective thickness (15, 50 or 80 nm) were sublimed
under high vacuum in an Edwards 306 sublimation chamber at a rate of 0.1 Ås−1 and
at a pressure of 2x10−6 mbar onto pre-cleaned glass coverslips. P13-coated coverslips
were then sterilized under the UV for 30 min. Afterwards, coating was applied as
described above (see 3.2.1.1).
3.2.2 O-CST
o-cst fabrication O-CST devices were fabricated in top-contact and bottom-
gate configuration with an additional capping layer of organic semiconducting ma-
terial on top of the contacts. The substrates consisted of glass coated with a 150 nm
thick layer of spattering deposited Indium Tin Oxide (ITO). Before deposition the
substrates were cleaned by multiple sonications in acetone and 2-propanol. 420 nm
of PMMA were deposited on top of the ITO layer by spin-coating in air and annealed
for 12 h a 120 ◦C in vacuum. The 15 nm thick P13 thin film was grown by sublimation
under high vacuum at a base pressure of 10−6 mbar in an Edwards 306 sublimation
chamber at a rate of 0.1 Ås−1. 30 nm thick gold electrodes were deposited in high
vacuum at a pressure of 3-4 x 10−6 mbar at a growth rate of 0.1 nm s−1. The channel
length between two gold electrodes was set to 70 µm. A 50 nm thick P13 capping
layer was vacuum sublimed on top of the gold electrodes under the same conditions
as described before. O-OCST devices were then sterilized under the UV for 30 min.
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Afterwards, additional coating for cell adhesion was applied as described above (see
3.2.1.1).
o-cst operation Specific voltage protocols were applied to the O-CST by a
custom-made 2612A Dual-channel System Source Meter Instrument (Keithley).
3.3 patch clamp
A general introduction into the working principles of the patch-clamp technique
can be found in section 2.3.1. Electrophysiological experiments were performed on
a setup based on a Nikon Eclipse Ti-S microscope. Whole-cell patch-clamp record-
ings were performed 24-72h after re-plating in voltage- or current-clamp mode at
RT using patch pipettes (2-4 MΩ tip-resistance) pulled from thin-walled borosilicate
glass capillaries. Responses were amplified (Multiclamp 700B, Axon Instruments),
digitized (Digidata 1440A, Axon Instruments) and stored on a computer for off-line
analysis. Further analyses were carried out using pClamp 10 (Axon Instruments) and
Origin 9.0 (OriginLab Corporation). Capacitative transients were compensated by the
nulling circuit of the recording amplifier. Because of the large current amplitude, the
access resistance (below 10 MΩ) was corrected 70-90%.
Ion channel blockers were diluted to their final concentration as described in table
3 in external standard solution (see table 4). The bath saline was then replaced by
saline containing the respective blocker and experiments were conducted after 5 min
of incubation time. When perfusing the cells with salines containing different phar-
macological agents, they were applied via a gravity-driven, local perfusion system
with a flow rate of about 200 µl/min,
BAPTA-AM 10 µM
Brilliant Blue 1 µM
Carbenoxolone 50 µM
Gadolinium(III)chloride 10 µM
HC30031 30 µM
RN-1734 10 µM
Ruthenium Red 10 µM
Table 3: Final concentrations of blockers applied for patch-clamp and calcium imaging exper-
iments prepared in external standard solution (see table 4)
3.3.1 Calculation of astrocytic electrophysiological properties
capacitance The capacitance of the cell membrane is proportional to the surface
area with about 1µF/cm2 [187]. The value the cell capacitance was taken directly be-
fore recording, using the cell capacitance compensation of the Multiclamp amplifier.
resting membrane potential The resting membrane potential (= zero cur-
rent potential) was obtained by setting the current given by the amplifier to zero.
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reversal potential The reversal potential was obtained from ramp current
trace recordings, plotting the current vs. the set voltage.
current density The maximal current density (Imax) was calculated by nor-
malizing the obtained current value (I) at a chosen voltage (for the inward current
density -120 mV, for the outward current density +60 mV) for the cell capacitance
(Cp):
Imax =
I
Cp
(2)
input resistance The input resistance (IR) was obtained from recorded current
traces, where the given stimulation was a voltage step (∆V , from VH= -60 mV to -120
mV for astrocytes). The change in current (∆I) was then used to calculate the input
resistance:
IR =
∆V
∆I
(3)
specific conductance The specific conductance (SG) was obtained from the
reciprocal of the input resistance (IR), normalized by the cell capacitance (Cp):
SG =
1
IR
Cp (4)
3.3.2 Calculation of neuronal firing properties
The capacitance and the resting Vmem (see figure 29-a) were obtained as described in
section 3.3.1. The action potential (AP) and neuronal firing properties were recorded
in current-clamp mode by injecting repetitive increasing current pulses from 25 to 250
pA of 100 ms duration. The AP amplitude was measured between the peak and AP
threshold level. The current threshold Ith was determined as the minimum current
injection required evoking an AP. The AP voltage threshold Vth was defined as the
first point on the upstroke of an AP (figure 29-b). The AP rising time to peak (figure
29-c) was defined as the time for rising from baseline to the AP peak (figure 29-d).
The after hyperpolarization potential (AHP) amplitude (figure 29-f) was measured
between the maximum hyperpolarization and the voltage plateau final. The AHP
duration was the time between these two points (figure 29-e). The maximal number
of firing was calculated by counting the number of overshooting AP in response to a
100 ms pulse of current injection [14].
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Figure 29: Parameters of DRG neuron action potentials. (a) Resting Vmem, (b) first point of
upstroke, (c) time to peak, (d) peak, (e) AHP duration, (f) AHP amplitude (modified from
[14])
3.3.3 Patch-clamp standard solutions
All salines for patch-clamp experiments were prepared with salts of the highest pu-
rity grade and de-ionized and sterilized water. After pH-adjustment with the respec-
tive acid or base, the osmolarity was adjusted with mannitol if not stated otherwise.
3.3.4 Standard solutions for astroytes
NaCl 140 mM
MgCl2 2 mM
KCl 4 mM
CaCl2 2 mM
HEPES 10 mM
Glucose 5 mM
Mannitol 20mM
pH 7.4 with 1N NaOH, osmolarity ∼ 315 mOsm
Table 4: External standard solution for astrocytes. [182]
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KCl 144 mM
MgCl2 2 mM
EGTA 5 mM
HEPES 10 mM
pH 7.2 with 1N KOH, osmolarity ∼ 295 mOsm
Table 5: Internal standard solution for astrocytes. [182]
CsCl 126 mM
MgCl2 2 mM
EGTA 1 mM
TES 10 mM
pH 7.2 with 1N CsOH, osmolarity ∼ 295 mOsm
Table 6: Internal CsCl-solution for astrocytes. [188]
NaCl 140 mM
MgCl2 4 mM
KCl 4 mM
HEPES 10 mM
EGTA 0.5 mM
Mannitol 20mM
pH 7.4 with 1N NaOH, osmolarity ∼ 315 mOsm
Table 7: Calcium free external standard solution for astrocytes. [182]
CsCl 140 mM
MgCl2 2 mM
CaCl2 2 mM
TES 10 mM
Glucose 5 mM
pH 7.4 with 1N CsOH, osmolarity ∼ 315 mOsm
Table 8: External cesium standard solution for astrocytes. [188]
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CsCl 22 mM
CaCl2 2 mM
MgCl2 2 mM
TES 10 mM
Glucose 5 mM
Gluconic acid 100 mM
pH 7.2 with 1N CsOH, osmolarity ∼ 295 mOsm
Table 9: Internal CsGluconate solution for astrocytes. [188]
3.3.5 Standard solutions for Dorsal Root Ganglia
NaCl 140 mM
MgCl2 2 mM
KCl 4 mM
CaCl2 2 mM
HEPES 10 mM
Glucose 5 mM
Mannitol 20mM
pH 7.4 with 1N NaOH, osmolarity ∼315 mOsm
Table 10: External standard solution for DRG neurons. [13]
KCl 144 mM
MgCl2 2 mM
NaATP 2 mM
EGTA 5 mM
HEPES 10 mM
pH 7.2 with 1N KOH, osmolarity ∼295 mOsm
Table 11: Internal standard solution for DRG neurons. [13]
3.4 fluorescein diacetate assay cell viability assay
The Fluorescein diacetate (FDA) assay was used to test the cell viability. Cells are
stained with cell-permeable FDA, a non- fluorescent fluorescein analogue. In living
cells it is hydrolysed to fluorescent fluorescein by cellular esterase activity, cleaving
off the acetate groups. In this way, living cells can be visualized by fluorescence
microscopy [189].
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The FDA stock solution (5 mg/ml) was prepared in acetone and 3.3 µl of the stock
solution was diluted in 1 ml of phosphate buffered saline (PBS). Astrocytes plated on
O-CSTs or coverslips were incubated with the FDA dilution for 5 min at RT, washed
with PBS and characterized by Nikon eclipse 80i fluorescent inverted microscope
equipped with a 20x or 40x air objective. Living cells were counted and the number
of cells/area was calculated and compared at each desired time point.
3.5 statistical analysis
Data were compared by one-way ANOVA with Bonferroni post-test or student’s t-test.
A statistically significant difference was reported if p<0.05 or less. Data are reported
as the mean ± Standard Error (SE) from at least three independent experiments.
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A B I O M O D I F I E D Q U AT E RT H I O P H E N E S E M I C O N D U C T O R A S
O R G A N I C N E U R A L I N T E R FA C E .
As described in 2.4.6, interfacing a semiconductor surface with cells requires still a
coating layer of extracellular matrix proteins to enable the adhesion and growth of
cells. These additional treatments are a nontrivial part within the fabrication proce-
dure and limit the use of currently available technologies for electrophysiological
recording by causing a decrease of the recording sensibility. For this purpose, a mod-
ified quaterthiophene bearing lysine-ends (T4Lys) was investigated as a functional
platform for neural cell growth, aiming to combine a material’s semiconducting func-
tionalities while at the same time enhancing cell adhesion and neurite outgrowth.
4.1 biocompatibility of t4lys with primary drg neurons
As a first step to assess the capability of T4Lys to enable adhesion and growth of
neural cells, primary DRG neuron cultures were plated on glass coverslips coated
with T4Lys, T4, and PLL. Fluorescein diacetate (FDA) viability assays were performed
after 2 and 8 div from cell plating. Fluorescent images, taken after 8 div (figure 30A),
revealed that viable cells could be found on coverslips coated with PLL and T4Lys
films. On contrary, almost no living cells could be detected on T4 crystals.
The histogram plot of averaged cell density (number of cells per area) at 2 and 8 div
(figure 30B) showed that the total number of cells in the culture (neuronal and non-
neuronal) was significantly lower on T4-Lys after 2 and 8 div compared to Glass+PLL
seeded cells (figure 30B, grey and orange bars). Additionally a significantly higher
number of cells was countable on T4Lys in comparison to pristine T4 at both time
points (figure 30B, blue bars under red arrow).
The reason in the decreased adhesion of DRG neurons on T4 and T4Lys can be
found in the material’s properties. In case of pristine T4, the material forms scattered
large rhomboidal crystals with a very high roughness and a decreased wettability/hy-
drophilicity (contact angle: 89.1 ± 2.6◦). On the contrary, T4Lysine forms a uniform
film, comparable to PLL on glass. Still T4Lys cast films show a considerably higher
roughness (23.2 ± 1.9 nm) in comparison to Glass+PLL (0.35 ± 0.01 nm) and a contact
angle of 44.8 ± 1.9◦, which is higher than the one of PLL coated glass (29.6 ± 2.6◦),
suggesting that lysine functionalization of T4 improves the wettability/hydrophilic-
ity with respect to the unmodified T4 substrate, but doesn’t fully reach the properties
of Glass+PLL [118]. Due to the negligible adhesion and growth of DRG neurons on
T4, this material was not included in the further investigation.
To confirm that cells found on T4Lysine were indeed neurons, cells were stained
for neuronal nuclear protein (NeuN), a neuronal nuclear antigen [190]. The average
of percentage of NeuN-positive cells, with respect to the total number of cells, was
found to be significantly higher in T4Lys plated DRG cultures than in Glass+PLL
plated ones (78 ± 1% for T4Lys and 49 ± 2% for PLL, see figure 31A) [118].
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Figure 30: (A) Confocal images of fluorescein diacetate (FDA)-stained DRG cell cultures
plated on Glass+PLL, casted T4 and T4Lys films, captured after 8 div. On pristine T4, due
to the formation of scattered large rhomboidal crystals, almost no cells were able to adhere.
(B) Histogram plot of FDA-positive cells, normalized by the area on DRG neurons grown
on PLL, casted T4, and T4Lys, after 2 and 8 div. Red arrows: T4 crystals did not allow cell
adhesion, therefor the number of cells is negligible (n=10 PLL, n=10 T4, and n=18 T4Lys for
2 div; n=10 PLL; n=10 T4, and n=18 T4Lys for 8 div. For each sample, 20 image fields were
taken and analyzed. ***p<0.001, One-way ANOVA).
In order to verify the impact of T4Lys on neuronal neurite re-growth, cells were
stained for growth-associated protein (GAP43), which is expressed in cell bodies
and outgrowing neurites of DRG neurons [191]. GAP43 immunofluorescent staining
performed after 5 div revealed not only the presence of neurons with axonal regen-
erating processes on T4Lys and Glass+PLL seeded neurons, but also that neurites of
neurons grown on T4Lys were almost 50% longer than those on Glass+PLL control
substrates (figure 31B).
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Figure 31: (A) Histogram plot of the number of NeuN-positive cells/area on Glass+PLL
(grey bar) and T4Lys (orange bar) plated cell cultures. (n=79 for PLL and n=95 for T4Lys;
***p<0.001, One-way ANOVA) (B) Histogram plot representing neurite length measured in
neurons grown on PLL (grey bar) and T4Lys (orange bar). (number of neurites measured
for each condition: n=386 for PLL and n=789 for T4Lys; ***p<0.001, One-way ANOVA)
Taken together, these results indicate that the lysine functionalization of T4 results
in enabling cell adhesion and differentiation of primary DRG neurons.
4.2 t4-lysine preserves the electrophysiological properties of drg
neurons
An important aspect of interfacing neurons with organic bioelectronics is the capa-
bility of the interface to preserve the bioelectrical properties of neurons. By these
means, whole-cell patch-clamp experiments on DRG neurons, 72 h after plating on
Glass+PLL and T4Lys samples, were performed as shown in figure 32. Cells were
voltage-clamped at a holding potential of −60mV in control intracellular and extra-
cellular saline (see tables 4 and 6), then families of current pulses from 25 to 250
pA amplitude with increasing steps of 25 pA and a duration of 100 ms were in-
jected to evoke neuronal action potentials. Representative current-clamp traces of the
first action potential (AP) evoked from cultured DRG neurons plated on Glass+PLL
and T4Lys are shown in figure 33A and B respectively. A comparative analysis of the
evoked action potential and calculated passive and excitability properties is displayed
in table 12.
Figure 32: Schematic representation of patch-clamp experiments of DRG neurons seeded on
T4Lysine coated coverslips.
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In response to threshold current injection, neuron depolarization lead to neuronal
firing, which occurred as single (figure 33) as well as repetitive (figure 34) firing in
T4Lys as well as Glass+PLL seeded neurons. A slightly higher number of neurons
with repetitive firing in T4Lys seeded cells compared to Glass+PLL cultured neu-
rons could be found. In Glass+PLL cultured neurons, from 24 cells only three cells
showed repetitive firing and 21 were firing single (phasic) action potentials. Of the 18
neurons analyzed in total on T4Lys, eight cells showed repetitive firing and ten cells
single firing. Accordingly, the maximal firing rate was higher in T4Lys firing neurons
compared to cells plated on Glass+PLL.
Figure 33: Representative traces of DRG neuron action potentials on Glass+PLL and T4Lys.
Dotted line represents the holding potential of -60 mV.
The comparative analysis of the average active and passive electrophysiological
properties revealed that the mean values of the cell capacitance were slightly higher
in neurons plated on T4Lys, indicating a lightly increased cell surface. A possible
explanation is the beginning of a significantly higher neurite outgrowth when short
stumps start departing from the soma and increasing the cell surface, which leads
in turn to a higher capacitance. A difference can also be reported for the resting
membrane potential (resting Vmem) which is depolarized in neurons plated on T4Lys
in comparison to Glass+PLL seeded cells and may serve as an explanation for the
higher firing rate. In the other examined parameters which included the AP threshold
current (Ith), the AP voltage threshold (Vth), AP peak, AP amplitude, time to peak
and after hyperpolarization period (AHP) amplitude, no statistical difference could
be found between the two experimental conditions.
Table 12: Passive and excitability properties of DRG neurons seeded on T4Lys.
Cp: membrane capacitance; Resting Vmem: resting membrane potential; Ith: threshold current;
Vth: voltage threshold; AP: action potential; AHP: after hyperpolarization period amplitude;
(n=24 for Glass+PLL and n=18 for Glass+T4Lys. *p<0.05, **p<0.01, One-way ANOVA
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Figure 34: Representative current-clamp traces of the repetitive firing evoked from cultured
DRG neurons on (A) PLL and (B) T4Lys in response to a pulse family of 100 ms duration.
For PLL cultured neurons, n=3 for repetitive firing and n=21 for single firing (n=24 in total).
For DRG neurons seeded on T4Lysine, n=8 for repetitive firing and n=10 for single firing
(n=18 in total). The dotted line represents the holding potential of -60 mV.
Figure 35: Representative traces of DRG neuron whole cell currents evoked with a step pro-
tocol on (A) Glass+PLL and (B) T4Lys seeded cells. Dotted line represents 0 nA. (C-D) I/V
plots: Mean values of maximal inward (C) and outward (D) current densities recorded in
neurons plated on PLL (black circles) and T4Lys (white circles). I/V plots have been gener-
ated by calculating the average of the maximal inward or outward current values recorded
at each potential, and normalized for the relative cell capacitance values.
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In order to obtain a profile of the whole-cell current of neurons plated on PLL
and T4Lys, current traces (figure 35) were evoked with a family of cells voltage steps
from a holding potential of −60 mV, from −120 mV to 60 mV in increments of 20
mV. The mean of maximal current density for each voltage step at peak and steady
state in Glass+PLL and T4Lys seeded cells was compared, revealing a similar voltage-
dependent profile of the whole cell current in the two conditions. The average thresh-
old voltage for inward current activation was −30 mV with a maximal conductance
at −20mV. DRG neurons displayed a comparable inward current at different voltages
and a similar maximum inward conductance (Gin max = 5.5 ± 1.1 ns pF−1 for PLL, n
= 9, and Gin max = 5.3 ± 0.9 ns pF−1 for T4Lys cells, n = 10). In contrast, the average
outward current recorded at voltages applied above 0 mV was significantly different
in the two experimental conditions. (Gout max = 4.1 ± 0.5 ns pF−1 for PLL, n = 9 and
Gout max = 3.2 ± 0.4 ns pF−1 for T4Lys cells, n = 10).
4.3 conclusions
With T4Lysine, an innovative, water processable lysinated molecular organic semi-
conducting material was introduced [118]. Our study showed that the Lys insertion
into T4 enables adhesion of primary culture of rat dorsal root ganglia. By whole-cell
patch-clamp, it could be confirmed that the biofunctionality of primary DRG neurons
cultured on this material was preserved. Collectively the data indicated that T4Lys is
a favorable organic interface to promote the in vitro growth of primary DRG neurons.
Moreover, the comparative quantitative analyses of the active and passive biophysi-
cal properties, in particular the difference in the resting membrane potential and the
resulting increased repetitive firing of cells seeded on the novel material hint that
T4Lys enables functional differentiation of primary DRG neurons. T4Lysine was the
first material to be reported, where the optical and iono-electronic functionalities as
well as the soft nature of an organic semiconducting material were combined with
lysine for improved biocompatibility. Our study has shown the proper functioning of
this innovative concept, which was then expanded on another semiconducting back-
bone: perylene diimide. In a second study, our group introduced the self-assembled
lysinated perylene diimide (PDI-Lys, [161], see also 2.4.6) that was also found to be
suitable to be interfaced with DRG neurons. These lysinated organic semiconductors
have opened the door for a new type of material to be chemically realized and then
integrated in bioorganic devices and can set the scene for a new step in terms of
sensitivity of bidirectional communication between cells and device by reducing the
cleft at the interface.
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5.1 p13 - a perylene-based material and device
As described in 2.4.4, Perylene Tetracarboxylic Diimide derivatives such as N,N0
-ditridecyl perylene-3,4,9,10 tetracarboxylic diimide (P13) belong to the most promis-
ing small organic molecules to fabricate n-type organic thin film transistors (OTFTs).
An organic field effect transistor (OFET) with P13 as semiconducting and capping
layer has already been realized and successfully integrated with dorsal root ganglia
[13]. Based on this work, P13 and a P13-OFET (hereinafter referred to as O-CST)
were investigated as an interface with primary cortical astrocytes. To this end, the
biocompatibility of P13 thin films with astrocytes was tested to determine the adhe-
sion and growth of astrocytes. By patch-clamp studies the impact of P13 on astrocytic
electrophysiological properties was studied. A further step was to interface cortical
astrocytes with the actual device and study the modulation of the astrocytic ionic
conductance with the patch-clamp technique while stimulating the cells by operating
the O-CST in accumulation mode. Finally, making use of the O-CST’s transparency,
calcium imaging was performed on astrocytes stimulated by the O-CST, monitoring
the changes of their intracellular Ca2+-level.
5.1.1 Biocompatibility of P13 thin films with astrocytes
In order to test if P13 could be a suitable substrate to be interfaced with astrocytes,
the first step was to evaluate the material’s biocompatibility. Confluent astrocytes
were re-plated at low density on coverslips coated with 50 nm P13. After 2, 7 and 15
days in vitro (div) from re-plating, fluorescein diacetate (FDA) cell viability assays
were performed. Figure 36 A and B display single plane confocal images taken after
2 and 7 div, showing viable astrocytes plated on P13+PDL and on Glass+PDL control
substrates.
Figure 36C shows the histogram plot of the cell counting study. The number of
cells per area at the chosen time points reveals that the rate of adhesion, survival
and proliferation was significantly higher on cells plated on P13+PDL substrates (red
bars) in comparison to the Glass+PDL control (blue bars) after 2 and 7 div. After
15 div this number was comparable again on the two substrates. These data indicate
that P13 is a biocompatible substrate not only for neural cells [13], but also suitable to
be interfaced with primary cortical astrocytes promoting their adhesion and growth.
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Figure 36: Fluorescent images taken after 2 and 7 DIV of astrocytes stained for FDA on
(A) Glass+PDL and (B) P13+PDL (C) Histogram plot of averaged FDA positive cells/area
counted on astrocytes plated on Glass+PDL and P13+PDL after 2, 7 and 15 div. A statistical
difference was observed after 2 and 7 div (n= 91 PDL and n=108 P13+PDL after 2 div, n=95
PDL and n=93 P13+PDL after 7 div, n=30 PDL and n=21 P13+PDL after 15 div. ** p<0.01,
One-way ANOVA).
5.1.2 Evaluation of astrocytic electrophysiological properties on P13 thin films
Primary cortical astrocytes in culture are characterized by a rapidly activating, non-
inactivating, voltage-dependent current pattern, mainly carried by K+ channels [183,
188]. PDL-plated cells display a depolarized resting membrane potential, high in-
put resistance and a low specific conductance [182]. To verify, if the contact with
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the organic material introduced any changes, whole-cell patch-clamp experiments
were performed on cells seeded at low density, 24h after re-plating, on P13+PDL and
Glass+PDL substrates. With control intra- and extracellular saline, cells were held
at -60 mV and after stepping to -120 mV for 500 ms, a ramp from -120 mV to +60
mV (500 ms, see inset 37B) was applied to evoke whole-cell currents. Typical cur-
rent traces evoked by the ramp protocol are shown in figure 37B for Glass+PDL and
P13+PDL seeded cells.
Figure 37: (A) Schematic representation of patch-clamp experiments on astrocytes seeded on
P13 thin films. (B) Traces representative of astrocytic response to voltage ramp protocol from
Vh of -60 mV, from -120 mV to +60 mV (depicted by the little inset). Dotted line represents
0 pA/pF.
The current amplitude was recorded and the membrane properties were calculated.
A summary is shown in table 13. The resting membrane potentials and the reversal
potential of cells plated on P13+PDL and Glass+PDL were comparable as well as the
capacitance. Even though no statistical difference can be reported for the maximum
inward current density, cells seeded on P13+PDL showed a slightly higher inward
current density in comparison to cells seeded on Glass+PDL control substrates. A
significant difference between the two conditions was observed in the input resis-
tance, where the one of P13+PDL seeded cells showed was lower.
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Table 13: Summary of electrophysiological properties of astrocytes seeded on Glass+PDL and
P13+PDL.
Cp, membrane capacitance; Vmem, resting membrane potential; Erev, reversal potential SG,
mean specific conductance; IR, input resistance; I, current density. (n=33 for Glass+PDL and
n=41 for astrocytes seeded on P13+PDL. **p<0.01, student’s t-test)
Figure 38: (A) Representative current traces evoked in astrocytes seeded on Glass+PDL and
P13+PDL with a family of voltage steps from Vh of -60 mV, from -120 to 60 mV in 20 mV
increments as depicted by the inset. (B-C) I/V- plots of the mean current density recorded
at peak (*, B) and steady state (**, C) in astrocytes plated on Glass+PDL (blue circles) and
P13+PDL (red circles). No statistical difference can be reported for peak and steady state
(n=26 for Glass+PDL and n=31 for P13+PDL, *p<0.05 one-way ANOVA).
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To investigate the conductance voltage-dependence of cells seeded on P13+PDL
and Glass+PDL, astrocytes were stimulated with 500 ms voltage steps (Vh=-60 mV)
from -120 mV to +60 mV in increments of 20 mV (inset figure 38A). Representative
current traces of astrocytes plated on P13+PDL and Glass+PDL are shown in figure
38A. A comparative analysis obtained by an I/V plot of the maximal current density
mean values, recorded for each voltage step, revealed a similar voltage-dependent
profile of whole-cell peak (figure 38B) and steady state (figure 38C) currents of astro-
cytes plated on P13+PDL and Glass+PDL samples and no statistical difference can
be reported.
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5.2.1 Evaluation of astrocytic electrophysiological properties on the O-CST
After testing the impact of P13 on the electrophysiological properties of primary cor-
tical astrocytes (see 5.1.2), also the effect of the O-CST was verified on the astrocytes’
electrophysiological properties. Even though the capping layer consists of 50 nm P13
like the coverslips, the P13 is not continously covering the complete O-CST surface,
which consists of in total 4 seperate devices. Between these devices, PMMA is in
contact with the tissue culture medium. Even though PMMA is described as biocom-
patible with living tissue and in particular astrocytes (see [192] and [193]), it can’t be
excluded that its interplay with P13 or circumstances arising from fabrication proce-
dures and technical specifications, could still alter the astrocytic electrophysiological
properties.
To this aim, whole-cell patch-clamp experiments were performed on single cells
seeded at low density on Glass+PDL control substrates and on the channel of PDL-
coated O-CSTs, 24h after re-plating. A scheme of the experimental setup is shown
in figure 39A. Whole-cell currents were evoked by voltage clamping cells in control
intracellular and extracellular saline at a holding potential (Vh) of -60 mV and, after
stepping to -120 mV for 400 ms, applying a ramp from -120 to 60 mV (500ms, see
inset in figure 39B). Representative current traces evoked by the ramp protocol are
shown in figure 39B for Glass+PDL and O-CST+PDL seeded cells.
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Figure 39: (A) Schematic representation of patch-clamp experiment on the O-CST with astro-
cytes seeded on the channel. (B) Representative ramp current traces of astrocytic response
to voltage ramp protocol (inset) from Vh of -60 mV to -120 mV then applying a slow ramp
to +60 mV, obtained under standard conditions. Dotted line represents 0 pA/pF.
Table 14: Electrophysiological properties of astrocytes on PDL-coated O-CSTs.
Cp, membrane capacitance; Vmem, resting membrane potential; SG, mean specific conduc-
tance; IR, input resistance; I, current density. (n=12 for Glass+PDL and n=14 for astrocytes
seeded on O-CST+PDL. * p<0.05, **p<0.01, one-way ANOVA)
A comparative analysis of these whole-cell patch-clamp experiments revealed that
cells seeded on the channel of the O-CST displayed a more depolarized resting mem-
brane potential (-26.7 ± 1.7 mV), a lower input resistance and higher specific conduc-
tance in comparison to PDL-seeded cells. No statistical difference could be reported
in the maximum outward current density, whereas the inward current density was
about two-fold increased in astrocytes seeded on O-CST+PDL. These differences in
the electrophysiological properties might suggest that different materials on the sur-
face of the O-CST together enable the differentiation of astroglial cells thereby altering
their inward conductance.
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Figure 40: (A) Representative current traces evoked in astrocytes seeded on Glass+PDL and
O-CST+PDL with a family of voltage steps from Vh of -60 mV, from -120 to 60 mV in 20 mV
increments as depicted by the inset. Asterisks mark peak (*) and steady state (**).
(B-C) I/V plots: Mean current recorded at peak and steady state in astrocytes plated on
Glass+PDL (blue circles) and O-CST+PDL (red circles). A statistical difference can be re-
ported for peak and steady state at negative voltages (n=15 for Glass+PDL and n=13 for
P13+PDL, p<0.01 one-way ANOVA).
Next the voltage dependence of the conductance of O-CST seeded cells was inves-
tigated and astrocytes therefor stimulated with 500 ms voltage steps (Vh=-60 mV)
from -120 mV to +60 mV in increments of 20 mV (see inset in figure 40A). Represen-
tative current traces of astrocytes plated on Glass+PDL and O-CST+PDL are shown
in figure 40A. A comparative analysis obtained by an I/V plot of maximal current
density mean values, recorded for each voltage step, revealed a voltage-dependent
profile of whole-cell peak (*, figure 40B) and steady state (**, figure 40C) current of
astrocytes plated on O-CST+PDL and Glass+PDL samples with statistical differences
in the whole-cell current evoked at negative voltages.
We next asked, what ion(s) were involved in this increased inward current. To this
end, we replaced K+ and Na+ in the intracellular solution fully with cesium and
used an bath saline without K+ (0[K+]out). The obtained resulting current profile
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(figure 41A, B) and the astrocytic current reversal potential (figure 41C, D) indicate
the occurance of a Cl−-conductance [194].
Figure 41: Patch-clamp experiments on broken O-CSTs with Cs-containing internal standard
solution and K+-free bath saline. (A) Representative current traces evoked in astrocytes
seeded on Glass+PDL and O-CST+PDL with a ramp protocol as displayed by the inset. (B)
Representative step current traces, evoked by a voltage step stimulation as displayed by the
inset. (n=10 for Glass+PDL and n=6 for O-CST+PDL, p<0.001, one-way Anova).
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5.2.2 Modulation of astrocytic whole-cell currents by the O-CST
As shown before, the O-CST is capable to enable depolarization and hyperpolar-
ization of the DRG neuron membrane potential [13]. To investigate if the electric
field spanned by the O-CST is also modulating the ionic conductance of astroglial
cells, single-cell patch-clamp experiments on cells seeded on top of the O-CST chan-
nel were performed. A schematic representation of the experimental configuration is
shown in figure 42A.
In standard intracellular and extracellular saline, cells were voltage clamped at
a holding potential of -60 mV and, after stepping to -120 mV for 400 ms, a slow
ramp (180 mV/500 ms) from -120 to 60 mV (upper inset in figure 42B, asterisk is
highlighting the ramp part of the stimulation protocol) was applied to evoke whole-
cell currents. We continuously recorded ramp-current traces obtained by applying
this voltage-clamp protocol while operating the O-CST in accumulation mode by
biasing the gate electrode from 0V to 1V (VGS=0-1V) and keeping the drain electrode
at 0V (VDS=0V). In this experimental condition, the device operation in the saline
solution does not exceed 1V in order to avoid detrimental Faradaic currents causing
redox reactions at the electrodes[195].
During the experiments, the Ag/AgCl reference electrode of the patch-clamp set-
up was immersed into the bath saline and connected to the source electrode of the
O-CST, thereby double-serving as the grounded reference for all bias stimulation
protocols.
The typical ramp current profile observed is shown in the I/V plot in figure 42B. The
time course analysis of the percentage change in current density was sampled and
analyzed every 15 seconds and is reported in figure 42C. We observed an increase in
the inward current density during device operation over time, which also persisted
30s after the end of stimulation (figure 42B, purple trace, figure 42C white circles). In
correspondence with the maximal stimulation provided by the O-CST when VGS=1V,
a peak in the inward current density can be observed at 85s (figure 42B, orange circle).
In comparison, there was only a negligible change in the maximum outward current
density (figure 42C, black circles) during and after operating the O-CST.
With intracellular and extracellular standard saline condition these effects were
accompanied by a positive shift in the astrocytic reversal potential (see also lower
inset in figure 42B) of 6.1 ± 2.3.mV, 30 s after stimulation with the O-CST. This
shift was confirmed by a continuous current-clamp recording performed to monitor
the membrane potential during the O-CST stimulation (figure 42D). These results
demonstrate, that stimulation provided by the O-CST modulates astrocytic inward
conductance.
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Figure 42: (A) Scheme of patch-clamp experiments on cells plated on O-CST device. (B) Ramp
current traces, plotted as a function of the applied voltage, evoked in response to a voltage
ramp protocol from -120 mV to +60 mV. Complete stimulation protocol is depicted by the
inset, the voltage ramp is highlighted by the asterisk. While running the voltage-clamp ramp
protocol, cells were stimulated operating the device with a transfer protocol with VGS=0-1V
and VDS=0V. Reported traces corresponds to typical current traces recorded before (green
trace, 1), at the end of device operation (after 85s of device operation, orange trace 2) and
30 s after switch-off of the O-CST (purple trace, 3). The zoom of the x-axis shows the shift
in the reversal potential observed upon and after stimulation of the cell with the O-CST.
(C) Time course of averaged percentage change in ramp current values with respect to
the control, calculated at -120 mV and +60 mV. The time points marked with 1 (green
circle), 2 (orange circle) and 3 (purple circle) corresponds to the time points marked with
the same number and colors in panel B (n=11). (D) Continuous current-clamp recording of
the resting membrane potential of an astrocyte recorded upon and after stimulation course
with transfer protocol in external and internal standard saline.
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Figure 43: (A) I/V plot of ramp current traces measured before (1, green), after 60s of device
operation (2, orange) and 35 s after operating the O-CST (3, purple) recorded in internal stan-
dard Cs-Gluconate saline and external standard solution containing Cesium. Ramp traces
were recorded as depicted by the inset. (B) Percentage change of current density over time
at -120 mV and +60 mV recorded upon and after stimulation course of the O-CST (VGS=0-1,
VDS=0) compared to control (before stimulation, 1, green) recorded in external and internal
standard solution containing Cesium (n=7). The points at 0s (1, green circle), 85s (2, orange
circle) and 120s (3, purple circle) correspond with the ramp current traces shown in (A).
To study this O-CST-activated current in further depth K+ and Na+ in the intra-
and extracellular solutions were replaced with cesium to avoid the occurance of these
currents and intracellular Cl− was partially replaced by cell impermeable gluconate.
Ramp current traces were recorded as before within this particular ionic condition
and are reported in figure 43A. Before O-CST stimulation a value of the reversal
potential of the control current towards 0 mV was recorded which is consistent with
the occurrence of a cationic current (figure 43A).
Moreover a dramatic change in the maximum outward current density due to Cs+
blockage of Kdr mediated outward currents was observed (figure 43B) [196]. The
membrane potential was evaluated during the external stimulation of the O-CST
and only a negligible shift in the membrane potential could be observed, giving
evidence that the observed activated inward current is mediated by a cation which is
largely active already at resting state. Collectively these findings indicate the possible
contribution of Ca2+ channels or another non-selective cation channel.
To this end, Ruthenium Red (RR), a potent inhibitor for a broad range of Ca2+
channels, including the TRPV family, TRPA1, several ryanodin-receptors and Ca2+-
binding proteins like calmodulin, was applied [197, 198].
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Figure 44: (A) Ramp current traces, were recorded as described above in presence of Ruthe-
nium Red that was added before O-CST stimulation to the external standard saline to a final
concentration of 10 µM. (B) Corresponding time course of averaged percentage change in
current density at -120 mV and +60 mV recorded upon and after stimulation with O-CST in
presence of 10 µM of RR. The time points marked with 1, green circle; 2, orange circle and
3, purple circle, correspond to the time points marked with the same number and colors in
panel A (n=5). (C) Ramp current traces recorded as described above in presence of 10 µM
RN-1734, applied to the external standard saline before recording. (D) Corresponding time
course of averaged percentage change in current density at -120 mV and +60 mV recorded
upon and after stimulation with O-CST in presence of 10 µM RN-1734. The time points
marked with 1, green circle; 2, orange circle and 3, purple circle, correspond with the time
points marked with the same number and colors in panel C (n=8).
Ramp current traces were recorded in internal and external standard saline and
10µM RR was applied prior to stimulation with O-CST (figure 44A). In this experi-
mental condition, we couldn’t observe either a change in the maximum inward (fig-
ure 44B, white circles) or outward (figure 44B, black circles) current density during
and after stimulation with the O-CST. Also no shift in the reversal potential was
found, even at the maximum voltage (VGS=1V) applied to the O-CST. These data sug-
gested that the observed current changes due to O-CST stimulation are mediated by
ion channels that are inhibited by RR.
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Among the different channels blocked by Ruthenium Red, TRPV4 as a non-selective
cation channel has been shown to be highly abundant in astrocytes in vitro and in
astrocytic endfeet in situ [188]. TRPV4 displays a high permeability for Ca2+ and
activated by a variety of stimuli as described in 2.2.2. So we tested first a possible
engagement of TRPV4 in the obtained response, the TRPV4-specific blocker RN-1734
(10 µM, [71]) was applied and ramp current traces recorded while operating the
O-CST as described above (figure 44C). In this experimental condition, no change
could be found in the inward current density before, during and after O-CST oper-
ation (figure 44D, white circles). Instead, a decrease in the outward current density
was observed after O-CST operation (figure 44D, black circles). The abolition of the
increase in the inward current density subsequent to O-CST provided stimulation
by the application of the TRPV4-specific antagonist RN-1734 substantiates a crucial
contribution of TRPV4 channels to the observed change in the inward current density.
The initial raise of [Ca2+]i and the following sustained phase after stimulation
under standard conditions match closely with TRPV4-mediated Ca2+ currents [188]
as well as the change in the current profile due to the use of RR and RN-1734. Off note,
during standard conditions, we observed an instability of Gigaohm seals, hinting a
change of the cell volume. Monitoring of the cell capacitance during stimulation with
the O-CST revealed an increase in the capacitance of 1.3 ± 0.5 pF, indicating a slight
cell swelling. This behavior could not be observed during the use of RR and RN-1734,
further underpinning the supposition of a TRPV4 involvement since it is well known
that this channel can be activated by cell swelling. Thereby it is plausible to assume
that the electric field provided by the O-CST is interacting with the lipid membrane
of the cells inducing a swelling which in turn activates TRPV4 [66].
In figure 44, it can be seen that Ruthenium Red is fully blocking the change of cur-
rent density evoked by device operation. The reason is its rather unspecific blocking
of a broad range of channels. After getting a first strong indication of the involvement
of TRPV4 by the use of RN-1734, we next asked whether there might be also other
ions and their channels involved in the obtained response.
To this end, we fully replaced K+ and Na+ in the intra- and extracellular solutions
with cesium to again avoid the occurrence of these currents and intracellular Cl−
was partially replaced by cell impermeable gluconate. While recording ramp current
traces and stimulating the cell with the O-CST as before, the cells were perfused with
the Cs- bath solution containing 10 µM RN-1734 (see figure 45A) to block TRPV4,
Brilliant Blue to examine a potential contribution of the P2X7-pathway and in another
experiment 30 µM HC030031 to block TRPA1 (see figure 45C). We found also in this
ionic condition that as before, with RN-1734 the change in the inward current density
can be abolished. Also no shift in the reversial potential could be observed. These
findings underline one more time the crucial contribution of the TRPV4 channel to
the obtained increase in the inward current density and the origin of the obtained
inward current is Ca2+.
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Figure 45: (A) Ramp current traces, recorded as described above while perfusing the cells
with Cs-bath saline containing 10 µM RN-1734 during O-CST stimulation. (B) Correspond-
ing time course of averaged percentage change in current density at -120 mV and +60 mV
recorded upon and after stimulation with O-CST in presence of 10 µM of RN-1734 in Cs-
bath saline. The time points marked with 1, green circle; 2, orange circle and 3, purple circle,
correspond to the time points marked with the same number and colors in panel A (n=5).
(C) Ramp current traces, recorded as described above while perfusing the cells with Cs-
bath saline containing 30 µM HC030031 during O-CST stimulation. (D) Corresponding time
course of averaged percentage change in current density at -120 mV and +60 mV recorded
upon and after stimulation with O-CST in presence of 30 µM HC030031. The time points
marked with 1, green circle; 2, orange circle and 3, purple circle, correspond with the time
points marked with the same number and colors in panel C (n=5).
To rule out a Ca2+-entry through the purinergic receptor P2X7, cells were perfused
with Cs-bath saline containing 10 µM l and 1 µM of Brilliant Blue. At both concentra-
tions of this blocker, cells showed almost immediately signs of blebbing, therefor no
results can be shown of this experimental condition as the combination of Cs-bath
saline and Brilliant Blue must be considered as cell toxic.
Surprisingly a rather similar picture can be found when perfusing the cell with
the TRPA1-specific blocker HC030031 in Cs-bath saline (see figure 45C). Only a very
small increase in the inward and outward current density due to stimulation with
the O-CST can be found and no shift in the reversial potential. Therefor it must be
taken into account that also TRPA1 could play a role in the obtained increase in
inward current density under standard conditions. TRPA1 could hereby be directly
activated itself by the spanning of the electric field due to device operation. But also a
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secondary onset via a stretch activated pathway due to the slight cell swelling might
have been thinkable.
5.2.3 The role of O-CST architecture and device integrity
In order to investigate the role of the specific O-CST device architecture in the ob-
served increase of inward current density, the impact of the O-CST structure integrity
and device working functionality on the astrocytic response was investigated. Figure
46A shows the leakage gate current of a working O-CST (green circles) and of an
O-CST with a leakage in the dielectric (red squares), recorded upon the stimulation
transfer protocol by biasing the gate electrode from 0V to 1V (VGS = 0 - 1V) and keep-
ing the drain electrode at 0V (VDS = 0V). Respectively, the working O-CST device has
a maximum leakage current of 2 nA whereas the device with leaking dielectric shows
a thousand fold higher leakage current of about 2 µA. A device compromised in this
way is not able to build up an electric field in the channel and thereby not providing
sufficient stimulation to the cells.
Figure 46: (A) I/V curve representing an O-CST with low gate leakage current (green trace)
in comparison to a device with a high leakage of 2 µA (red trace). (B) Time course of percent-
age change in current density at -120 mV and +60 mV upon and after O-CST stimulation
recorded on cells plated O-CSTs with a high gate leakage current of 2 µA (n=3). Note that
the leakage current is not changing over time.
Again we performed patch-clamp experiments, continuously recording ramp traces
with the same settings as described in figure 42B. The corrupted O-CST was operated
in accumulation mode where VGS was spanned from 0 to 1 V within a duration of
85 s, while VDS was kept at 0V (see stimulation protocol in figure 46B). Figure 46B
shows the changes in inward and outward current density of astrocytes seeded on
an O-CST with a gate leakage-current of 2 µA. With the corrupted device, only a
decreased percentage change of the maximum current density during and after stim-
ulation with the O-CST with respect to a working device could be observed. This
finding shows, that it is indeed the stimulation by the electric field built up by a
working O-CST device that evokes the prior observed changes in the inward current
density of astrocytes seeded on the channel as described in 5.2.2.
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5.3 conclusions
By the means of patch-clamp experiments, it could be demonstrated that the O-CST is
capable of stimulating astrocytes seeded on top of the channel and thereby increasing
astrocytic inward current. By the use of specific blockers, this response could be
attributed to an influx of Ca2+ through mainly two members of the TRP-family:
TRPV4 and TRPA1. But also the integrity and function of the O-CST was found to
play a major role.
The TRPV4 channel, as a member of the vannilloid subfamily of TRP-channels, is
activated by a broad variety of chemical and physical stimuli and displays a large
permeability for Ca2+ over other monovalent cations [199]. In the brain, TRPV4 was
shown by immunogold-staining to be highly expressed in astrocytic endfeet in situ,
which are also enriched in AQP4. Astrocytic endfeed are abutting the blood capil-
laries and the pial surface [188]. TRPV4 has been discussed as an osmosensor, for
it has been shown to be involved in osmoregulation [200, 201]. By interacting with
AQP4, TRPV4 has been shown to play a role in cell volume regulation, for a manip-
ulation of the TRPV4 and AQP4 expression led to changes in the regulatory volume
decrease following a hypotonic challenge [202]. In adult rats, TRPV4 has been shown
to be involved ischemia-induced Ca2+-entry and been suspected to play a role in the
pathogenic mechanism leading for example to cell swelling [203].
TRPA1 as the sole member of the anikyrin-subfamily in mammals is also a promis-
cuous channel when it comes to the stimuli activating it. It was found to be pre-
dominantly expressed in sensory neurons [78], for example co-expressed with the
capsaicin receptor TRPV1 in DRG-neurons, where it is thought to be an irritant sen-
sor. TRPA1, was described as a transducer of irritant stimuli into nociceptor activity,
thereby playing a role in pain and acute inflammation [204]. TRPA1 was also debated
to be a mechanosenor necessary in auditory transduction, because hair cells of the
inner ear were found to express TRPA1 on the RNA and protein level, even though it
couldn’t be confirmed in knock-out mice studies [205]. In astrocytes, it was reported
to be regulator of astrocytic basal calcium levels [76].
Even though the O-CST can be seen as a stepstone to create novel tools for under-
standing the complex background in astrocytic Ca2+-signalling, there are still ques-
tions left open for follow-up studies. Also the current setup of the O-CST leaves room
for improvement. As discussed above, P13, the capping layer of the O-CST is a ma-
terial that is highly hydrophobic, thereby requires still treatment with PDL to enable
cell adhesion. The question that arises directly from this fact is: would the astrocytic
response be comparable, yet even stronger with the use of an O-CST? Seeding cells on
the O-CST for patch-clamp experiments revealed that cell adhesion took place mostly
outside the channel, even with coating of PDL. Without additional treatment, almost
no cells were found on the channel, so this experimental scenario was not feasible.
To overcome this major issue of the O-CST, new materials were investigated. In this
context the group of Valentina Benfenati (CNR-ISOF, Bologna) characterized a new
perylene diimide material bearing lysine end substituents (PDI-Lys, see [161]). The
introduced lysine ends enabled water processability of the perylene diimide deriva-
tive. Furthermore, the ionic nature of the lysine framework enhanced the overall
hydrophilicity of the final material, overcoming one of the major disadvantages of
P13 in terms of cell adhesion: its high hydrophobicity. The lysine functionalization of
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PDI promoted good cell adhesion of neural cells and a high in vitro biocompatibility
and differentiation of the neural cells while skipping the step of additional coating
with Poly-Lysine. Taken together with the good filmability and electrical transport
of PDI-Lys, this material could be a suitable candidate as active layer in organic elec-
tronics for neural interfacing. Also because the response of astrocytes to low and high
frequency stimulation was shown in 2015 by two different groups [206, 207], an O-
CST with a capping layer that improves cell adhesion and reduces the cleft between
the organic interface and the cells, may serve as a simple tool to finally help unravel
the role of TRPV4 and TRPA1 channels, their interplay and their specific functions in
CNS physiology and pathophysiology.

6
P R O J E C T S U M M A RY A N D O U T L O O K
The first part of the results obtained during my PhD show that the novel material T4-
Lys, a quaterthiophene bearing lysine-ends, is biocompatible with DRG neurons and
enables cell adhesion and promotes the outgrowth of neurites without the need of
any further coating of the interface. The alteration of the electrophysiological proper-
ties and the enhanced firing rate indicate that T4Lys enables functional differentiation
of DRG primary neurons. These pieces of evidence indicate that T4Lys is a suitable
organic interface for DRG primary neurons.
The second part of the results were aimed to test the suitability of the O-CST, an
organic field effect transistor that had been shown to work as both a cell stimulat-
ing and cell response sensing device with primary DRG neurons, as an interface
with primary astroglial cells. We could show that the organic field effect transistor
structure whose P13 capping layer was introduced as a biocompatible substrate to
be interfaced with DRG neurons, was also a biocompatible with astroglial cells. The
device treated with PDL as an additional coating was able to promote astrocytic ad-
hesion and growth. The astrocytic electrophysiological properties were found to be
preserved. We were able to stimulate astrocytes with these O-CST devices in accu-
mulation mode (VGS = 0-1V and VDS = 0V, transfer stimulation protocol) and could
determine by patch-clamp experiments that the provided stimulation addresses the
astrocytic whole-cell inward current. By the use of different blockers (Ruthenium
Red, RN-1734 and HC030031) and Cs-bath saline during stimulation, we found that
the ion responsible for the response was Ca2+ and we could attribute the obtained
modulation of the inward current to the TRPV4 and TRPA1 channels. When stim-
ulating the cells with the O-CST while parallel reading out the astrocytic calcium
response, we found that the stimulation by the O-CST (VGS = 0-1V and VDS = 0V)
evokes an increase in intracellular Ca2+, which is perfectly in line with the findings
of the patch-clamp studies, where we found an increased inward flux of Ca2+. Fi-
nally, the dependence of astrocytic response on the O-CST device architecture and
functionality could be demonstrated, where a lack of the proper localized field effect
did not lead to the response obtained with a fully functional O-CST.
The research and the obtained results during my PhD-studies opened the door
for several interesting follow-up studies. After testing the O-CST separately on DRG
neurons and cortical astrocytes, a next step might be to test neurons and astrocytes
together, also in regard of their interplay upon stimulation. Furthermore with the
introduction of T4Lys and PDILys, in the near future the additional coating of the
O-CST can probably be skipped by integrating these novel materials into the device.
This might help to overcome the major issue of P13’s hydrophobicity and thereby
making the O-CST an important stepping stone on the way of bridging the brain to
the world.
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